Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.
Steroidal compounds related to PROGESTERONE, the major mammalian progestational hormone. Progesterone congeners include important progesterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with progestational activities.
A synthetic progestin which is useful for the study of progestin distribution and progestin tissue receptors, as it is not bound by transcortin and binds to progesterone receptors with a higher association constant than progesterone.
A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.
A synthetic progestational hormone with actions similar to those of PROGESTERONE but functioning as a more potent inhibitor of ovulation. It has weak estrogenic and androgenic properties. The hormone has been used in treating amenorrhea, functional uterine bleeding, endometriosis, and for contraception.
The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, DYSPAREUNIA, and progressive development of OSTEOPOROSIS. This may also include the use of progestational agents in combination therapy.
Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives.
(6 alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione. A synthetic progestational hormone used in veterinary practice as an estrus regulator.
A synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or (+-)-form has about half the potency of the levo form (LEVONORGESTREL). Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis.
Pregnadienes which have undergone ring contractions or are lacking carbon-18 or carbon-19.
Progesterones which have undergone ring contraction or which are lacking carbon 18 or 19.
A synthetic progestational hormone with actions similar to those of PROGESTERONE and about twice as potent as its racemic or (+-)-isomer (NORGESTREL). It is used for contraception, control of menstrual disorders, and treatment of endometriosis.
A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate (52-62%) and equilin sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate.
The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.
Unsaturated pregnane derivatives containing two keto groups on side chains or ring structures.
Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.
A synthetic progestational hormone used often as the progestogenic component of combined oral contraceptive agents.
Pregnenes with one double bond or more than three double bonds which have undergone ring contractions or are lacking carbon-18 or carbon-19..
Metabolites or derivatives of PROGESTERONE with hydroxyl group substitution at various sites.
Oral contraceptives which owe their effectiveness to synthetic preparations.
Fixed drug combinations administered orally for contraceptive purposes.
A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING SYNDROME.
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
A biologically active 20-alpha-reduced metabolite of PROGESTERONE. It is converted from progesterone to 20-alpha-hydroxypregn-4-en-3-one by the 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE in the CORPUS LUTEUM and the PLACENTA.
A synthetic progestational hormone with actions and uses similar to those of PROGESTERONE. It has been used in the treatment of functional uterine bleeding and endometriosis. As a contraceptive, it has usually been administered in combination with MESTRANOL.
Therapeutic use of hormones to alleviate the effects of hormone deficiency.
A biologically active 5-alpha-reduced metabolite of plasma PROGESTERONE. It is the immediate precursor of 5-alpha-pregnan-3-alpha-ol-20-one (ALLOPREGNANOLONE), a neuroactive steroid that binds with GABA(A) RECEPTOR.
Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.
Benign proliferation of the ENDOMETRIUM in the UTERUS. Endometrial hyperplasia is classified by its cytology and glandular tissue. There are simple, complex (adenomatous without atypia), and atypical hyperplasia representing also the ascending risk of becoming malignant.
17-Hydroxy-6-methylpregna-3,6-diene-3,20-dione. A progestational hormone used most commonly as the acetate ester. As the acetate, it is more potent than progesterone both as a progestagen and as an ovulation inhibitor. It has also been used in the palliative treatment of breast cancer.
Oral contraceptives which owe their effectiveness to hormonal preparations.
Intrauterine devices that release contraceptive agents.
Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.
A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.
A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive.
The physiological period following the MENOPAUSE, the permanent cessation of the menstrual life.
The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.
A synthetic progestational hormone with no androgenic or estrogenic properties. Unlike many other progestational compounds, dydrogesterone produces no increase in temperature and does not inhibit OVULATION.
Unsaturated derivatives of the steroid androstane containing at least one double bond at any site in any of the rings.
An orally active synthetic progestational hormone used often in combinations as an oral contraceptive.
An agent with anti-androgen and progestational properties. It shows competitive binding with dihydrotestosterone at androgen receptor sites.
Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug.
A 6-methyl PROGESTERONE acetate with reported glucocorticoid activity and effect on ESTRUS.
Megestrol acetate is a progestogen with actions and uses similar to those of the progestogens in general. It also has anti-androgenic properties. It is given by mouth in the palliative treatment or as an adjunct to other therapy in endometrial carcinoma and in breast cancer. Megestrol acetate has been approved to treat anorexia and cachexia. (From Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)
A group of enzymes that catalyze the reversible reduction-oxidation reaction of 20-hydroxysteroids, such as from a 20-ketosteroid to a 20-alpha-hydroxysteroid (EC 1.1.1.149) or to a 20-beta-hydroxysteroid (EC 1.1.1.53).
Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
Physiologic period, characterized by endocrine, somatic, and psychic changes with the termination of ovarian function in the female. It may also accompany the normal diminution of sexual activity in the male.
C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of ESTRADIOL to resemble TESTOSTERONE but less one carbon at the 19 position.
Bleeding from blood vessels in the UTERUS, sometimes manifested as vaginal bleeding.
Occurrence or induction of ESTRUS in all of the females in a group at the same time, applies only to non-primate mammals with ESTROUS CYCLE.
Tumors or cancer of the human BREAST.
A synthetic fluorinated steroid that is used as a progestational hormone.
A metabolite of PROGESTERONE with a hydroxyl group at the 17-alpha position. It serves as an intermediate in the biosynthesis of HYDROCORTISONE and GONADAL STEROID HORMONES.
Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading.
Pregnane derivatives in which two side-chain methyl groups or two methylene groups in the ring skeleton (or a combination thereof) have been oxidized to keto groups.
A synthetic progestational dihydroxy derivative of PROGESTERONE. Its acetonide possesses anti-inflammatory properties.
Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important.
The 3-methyl ether of ETHINYL ESTRADIOL. It must be demethylated to be biologically active. It is used as the estrogen component of many combination ORAL CONTRACEPTIVES.
Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.
A pregnane found in the urine of pregnant women and sows. It has anesthetic, hypnotic, and sedative properties.
Enzymes that catalyze the oxidation of estradiol at the 17-hydroxyl group in the presence of NAD+ or NADP+ to yield estrone and NADH or NADPH. The 17-hydroxyl group can be in the alpha- or beta-configuration. EC 1.1.1.62
Excision of the uterus.
The period in the ESTROUS CYCLE associated with maximum sexual receptivity and fertility in non-primate female mammals.
A 21-carbon steroid, derived from CHOLESTEROL and found in steroid hormone-producing tissues. Pregnenolone is the precursor to GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS.
Chemical substances that prevent or reduce the probability of CONCEPTION.
Tumors or cancer of the UTERUS.
A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed)
The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.
An inactive metabolite of PROGESTERONE by reduction at C5, C3, and C20 position. Pregnanediol has two hydroxyl groups, at 3-alpha and 20-alpha. It is detectable in URINE after OVULATION and is found in great quantities in the pregnancy urine.
The surgical removal of one or both ovaries.
An enzymes that catalyzes the reversible reduction-oxidation reaction of 20-alpha-hydroxysteroids, such as from PROGESTERONE to 20-ALPHA-DIHYDROPROGESTERONE.
Saturated derivatives of the steroid pregnane. The 5-beta series includes PROGESTERONE and related hormones; the 5-alpha series includes forms generally excreted in the urine.
The discharge of an OVUM from a rupturing follicle in the OVARY.
Compounds which inhibit or antagonize the biosynthesis or action of estradiol.
An anabolic steroid used mainly as an anabolic agent in veterinary practice.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
Steroidal compounds related to ESTRADIOL, the major mammalian female sex hormone. Estradiol congeners include important estradiol precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with estrogenic activities.
The yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE.
The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE.
A synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. It possesses some androgenic properties. Danazol has been used in the treatment of endometriosis and some benign breast disorders.
The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
Chemical substances which inhibit the process of spermatozoa formation at either the first stage, in which spermatogonia develop into spermatocytes and then into spermatids, or the second stage, in which spermatids transform into spermatozoa.
A potent androgenic metabolite of TESTOSTERONE. It is produced by the action of the enzyme 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE.
A synthetic progestational hormone without significant estrogenic or androgenic properties. It was formerly used as the progestational component in oral sequential contraceptives.
Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.
Drugs administered orally and sequentially for contraceptive purposes.
Chemical compounds that induce menstruation either through direct action on the reproductive organs or through indirect action by relieving another condition of which amenorrhea is a secondary result. (From Dorland, 27th ed)
Abnormal uterine bleeding that is not related to MENSTRUATION, usually in females without regular MENSTRUAL CYCLE. The irregular and unpredictable bleeding usually comes from a dysfunctional ENDOMETRIUM.
Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.
Steroids containing the fundamental tetracyclic unit with no methyl groups at C-10 and C-13 and with no side chain at C-17. The concept includes both saturated and unsaturated derivatives.
Catalyze the oxidation of 3-hydroxysteroids to 3-ketosteroids.
Physiological mechanisms that sustain the state of PREGNANCY.

Mechanism of action and clinical effects of antiprogestins on the non-pregnant uterus. (1/878)

Considerable progress has been made in elucidating the mechanism of action of antiprogestins. The biological response to a progesterone antagonist depends on many factors. The usual effect is that of an antagonist, but progesterone agnostic or even antioestrogenic or oestrogenic effects have also been observed. The present review focuses on the clinical applications of antiprogestins in the non-pregnant uterus. Whereas high doses of antiprogestins block ovulation, low doses impair endometrial development without affecting ovulation, hormonal levels or bleeding patterns Indeed, the endometrium is the tissue which is the most sensitive to antiprogestins. The effect of antiprogestins is to produce a delay in endometrial maturation and to postpone the appearance of the implantation window. This concept of 'endometrial contraception' requires further testing in humans, although the principle has been proven in monkeys. In contrast to the low doses of mifepristone which delay endometrial maturation, a minimum dose of 50 mg is required to produce endometrial bleeding. Late luteal phase antiprogestin administration does not disturb ovulation, hormonal levels or bleeding patterns. This has clinical application, and mifepristone has been used together with prostaglandins in women with delayed menses to successfully prevent implantation. Mifepristone has also been shown to be an effective post-coital agent. However, when used on a regular basis once monthly at the end of the cycle as a potential contraceptive, the results are disappointing. Because of their antiproliferative and anti-oestrogenic effects on the endometrium, antiprogestins are also used in the treatment of oestrogen-dependent conditions such as endometriosis and fibromyomas. In humans, chronic administration of high doses of antiprogestins has on rare occasions been associated with endometrial hyperplasia, presumably a consequence of unopposed oestrogen activity. This does not occur with low doses (1 mg daily for 5 months).  (+info)

Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor complementary DNA. (2/878)

Because progesterone exerts its effects mainly via estrogen-dependent progesterone receptor (PgR), the expression of progesterone's effects may be overshadowed by the priming effect of estrogen. PgR expression vectors were transfected into estrogen receptor (ER)-alpha and PgR-negative breast cancer cells MDA-MB-231; thus the functions of progesterone could be studied independent of estrogens and ERs. Eight stable transfectant clones expressing both PgR isoform A and B were studied for their growth response to progesterone and its analogues. Although progesterone had no effect on growth in the control transfectant, the hormone markedly inhibited DNA synthesis and cell growth in all of the PgR-transfectants dose-dependently from 10(-12)-10(-6) M. This growth inhibition was associated with an arrest of cells in the G0/G1 phase of the cell cycle. Progestins medroxyprogesterone acetate, Org2058, and R5020 also strongly inhibited DNA synthesis, and their doses required for maximal inhibition of 60-70% were 10(-17) M, 10(-13) M, and 10(-7) M, respectively. Antiprogestin ZK98299 alone had no effect, but the compound was capable of counteracting the inhibitory effect of progesterone. In contrast, RU486 inhibited DNA synthesis, and it showed no further effects when it was used concurrently with progesterone. These results indicate that progestins are per se antiproliferative via a PgR-mediated mechanism in breast cancer cells. More importantly, we have shown that progestins may exert effective inhibitory control over the cell growth if the PgR expression is reactivated in ER- and PgR-negative breast cancer cells.  (+info)

Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial. (3/878)

BACKGROUND: Currently there is considerable interest in the potential health benefits of oil seeds, such as soy and flaxseed, especially in relation to cardiovascular disease and cancer. OBJECTIVE: We therefore evaluated health aspects of partially defatted flaxseed in relation to serum lipids, indicators of oxidative stress, and ex vivo sex hormone activities. DESIGN: Twenty-nine hyperlipidemic subjects (22 men and 7 postmenopausal women) completed two 3-wk treatment periods in a randomized, crossover trial. Subjects were given muffins that contributed approximately 20 g fiber/d from either flaxseed (approximately 50 g partially defatted flaxseed/d) or wheat bran (control) while they consumed self-selected National Cholesterol Education Program Step II diets. Both muffins had similar macronutrient profiles. Treatment phases were separated by > or = 2 wk. RESULTS: Partially defatted flaxseed reduced total cholesterol (4.6+/-1.2%; P = 0.001), LDL cholesterol (7.6+/-1.8%; P < 0.001), apolipoprotein B (5.4+/-1.4%; P = 0.001), and apolipoprotein A-I (5.8+/-1.9%; P = 0.005), but had no effect on serum lipoprotein ratios at week 3 compared with the control. There were no significant effects on serum HDL cholesterol, serum protein carbonyl content, or ex vivo androgen or progestin activity after either treatment. Unexpectedly, serum protein thiol groups were significantly lower (10.8+/-3.6%; P = 0.007) at week 3 after the flaxseed treatment than after the control, suggesting increased oxidation. CONCLUSIONS: These data indicate that partially defatted flaxseed is effective in lowering LDL cholesterol. No effects on lipoprotein ratios, ex vivo serum androgen or progestin activity, or protein carbonyl content were observed. The significance of increased oxidation of protein thiol groups with flaxseed consumption requires further investigation.  (+info)

Hormone replacement therapy, inflammation, and hemostasis in elderly women. (4/878)

Lipid-lowering by postmenopausal hormone therapy (HRT) explains only partly the assumed coronary risk reduction associated with therapy. To explore other possible mechanisms, we studied associations of HRT use with inflammation and hemostasis risk markers in women >/=65 years of age. Subjects were selected from 3393 participants in the fourth year examination of the Cardiovascular Health Study, an observational study of vascular disease risk factors. After excluding women with vascular disease, we compared levels of inflammation and hemostasis variables in the 230 women using unopposed estrogen and 60 using estrogen/progestin, with those of 196 nonusers selected as controls. Compared with nonusers, unopposed estrogen use was associated with 59% higher mean C-reactive protein (P<0.001), but with modestly lower levels of other inflammation indicators, fibrinogen, and alpha-1 acid glycoprotein (P<0.001). Factor VIIc was 16% higher among estrogen users (P<0.001), but this was not associated with higher thrombin production (prothrombin fragment 1-2), or increased fibrin breakdown (D-dimer). Concentration of plasminogen activator inhibitor-1 was 50% lower in both using groups (P<0.001) compared with nonusers, and this was associated with higher plasmin-antiplasmin complex: 8% higher in estrogen and 18% higher in estrogen/progestin users (P<0. 05). Relationships between the markers and hormone use were less pronounced in estrogen/progestin users, with no association for C-reactive protein except in women in upper 2 tertiles of body mass index (P for interaction, 0.02). The direction and strength of the associations of HRT use with inflammation markers differed depending on the protein, so it is not clear whether HRT confers coronary risk reduction through an inflammation-sensitive mechanism. Associations with hemostasis markers indicated no association with evidence of procoagulation and a possible association with increased fibrinolytic activity.  (+info)

Low use of long-term hormone replacement therapy in Denmark. (5/878)

AIMS: To examine individual use of hormone replacement therapy (HRT) in a defined population of Danish women during a 5-year period. HRT may reduce osteoporosis and cardiovascular disease in postmenopausal women, but may also have side-effects. Little is known about the use of HRT in most populations. METHODS: A Pharmacoepidemiological Prescription Database was used to identify all reimbursed prescriptions for HRT in the county during the period 1991 to 1995. The Danish retail pharmacies' drug subsidy system made it possible to identify prescriptions by individual use. RESULTS: We examined 255797 HRT prescriptions issued during the period in the County of North Jutland. Total sales reached 16.5 million defined daily doses (DDDs), purchased by 31653 women, which corresponds to 26.9% of the female population above the age of 39 years. The annual prevalence proportion of current users rose from 10.4% to 14.8% during the study period, and the therapeutic intensity (DDD/1000 women/day) increased from 20.6 to 32.0. The mean DDD sum of systemic HRT per user was 73.4 in 1991; it and the proportion of users who received less than 90 DDD per year (83.4% in 1991) remained almost constant during the study period. The amount of oestrogen unopposed by progestin was high, 28.1% of all prescriptions. CONCLUSIONS: Less than one-fifth of the study population used HRT for more than 3 months per year, and only 32.8% of the women who were new users of HRT in 1992 continued this therapy throughout the study period.  (+info)

Combined oestrogen-progestogen replacement therapy does not inhibit low-density lipoprotein oxidation in postmenopausal women. (6/878)

AIMS: The use of oestrogen containing hormone replacement therapy (HRT) is related to a significantly reduced atherosclerotic cardiovascular risk in postmenopausal women. Oestrogen is thought to be antioxidant and may inhibit low-density lipoprotein (LDL) oxidation in vitro. We investigated the effect of combined oestrogen and progestogen HRT on LDL oxidation in postmenopausal women. METHODS: Eighteen healthy women were given oestrogen/progestogen, and the susceptibility of LDL to oxidation was measured as the level of autoantibody to oxidative modified LDL and the production of conjugated dienes during copper-dependent oxidation after 3 and 6 months HRT. The levels of vitamin E, the major antioxidant in LDL, were also measured. RESULTS: After HRT, the anti-oxidatively modified LDL antibody level remained unchanged [1.58+/-0.16, 0.10 (-0.10, 0.26), and 0.08 (-0.09, 0.19), mean+/-s.d. at baseline, and mean change with 95% confidence intervals for differences at 3 and 6 months, respectively, P>0.05] as did the production of conjugated dienes when determined as lag phase [51.2+/-7.5, -0.3 (-3.9, 3.3), and 1.5 (-3.4, 6.4) min, P>0.05]. The LDL vitamin E content, measured as alpha-tocopherol, was also not altered [2.34+/-0.54, -0.07 (-0.27, 0.13), and -0.07 (-0.33, 0.16) nmol mg(-1) LDL, P>0.05] by treatment. CONCLUSIONS: Combined oestrogen and progestogen therapy for 6 months in postmenopausal women does not protect LDL against oxidation.  (+info)

Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. (7/878)

The recent findings that oestradiol and progestins activate the Src/Ras/Erks signalling pathway raise the question of the role of this stimulation. Microinjection experiments of human mammary cancer-derived cells (MCF-7 and T47D) with cDNA of catalytically inactive Src or anti-Ras antibody prove that Src and Ras are required for oestradiol and progestin-dependent progression of cells through the cell cycle. The antitumoral ansamycin antibiotic, geldanamycin, disrupts the steroid-induced Ras-Raf-1 association and prevents Raf-1 activation and steroid-induced DNA synthesis. Furthermore, the selective MEK 1 inhibitor, PD 98059, inhibits oestradiol and progestin stimulation of Erk-2 and the steroid-dependent S-phase entry. The MDA-MB231 cells, which do not express oestradiol receptor, fail to respond to oestradiol in terms of Erk-2 activation and S-phase entry. Fibroblasts are made equally oestradiol-responsive in terms of DNA synthesis by transient transfection with either the wild-type or the transcriptionally inactive mutant oestradiol receptor (HE241G). Co-transfection of catalytically inactive Src as well as treatment with PD98059 inhibit the oestradiol-dependent S-phase entry of fibroblasts expressing either the wild-type oestrogen receptor or its transcriptionally inactive mutant. The data presented support the view that non-transcriptional action of the two steroids plays a major role in cell cycle progression.  (+info)

Measuring endocrine profiles of women in field studies. (8/878)

Improved methods are needed to evaluate the effects of occupational and environmental hazards on the reproductive health of human female populations. This communication describes highly specific, sensitive, and reliable time-resolved fluorescence immunoassays for measuring luteinizing hormone (LH) and follicle-stimulating hormone (FSH), estrone 3-glucuronide (E13G), and pregnanediol 3-glucuronide (Pd3G) in urine, a fluid that is convenient and painless to collect serially from large populations. Furthermore, some of the technical issues relevant to the successful application of these measurements to field studies are discussed.  (+info)

Progestins are a class of steroid hormones that are similar to progesterone, a natural hormone produced by the ovaries during the menstrual cycle and pregnancy. They are often used in hormonal contraceptives, such as birth control pills, shots, and implants, to prevent ovulation and thicken the cervical mucus, making it more difficult for sperm to reach the egg. Progestins are also used in menopausal hormone therapy to alleviate symptoms of menopause, such as hot flashes and vaginal dryness. Additionally, progestins may be used to treat endometriosis, uterine fibroids, and breast cancer. Different types of progestins have varying properties and may be more suitable for certain indications or have different side effect profiles.

Progesterone congeners refer to synthetic or naturally occurring compounds that are structurally similar to progesterone, a steroid hormone involved in the menstrual cycle, pregnancy, and embryogenesis. These compounds have similar chemical structures to progesterone and may exhibit similar physiological activities, although they can also have unique properties and uses. Examples of progesterone congeners include various synthetic progestins used in hormonal contraceptives and other medical treatments.

Promegestone is a synthetic progestin, which is a type of hormone that is similar to the natural progesterone produced in the human body. It is used primarily as a component of hormonal contraceptives and for the treatment of various conditions related to hormonal imbalances.

In medical terms, promegestone can be defined as:

A synthetic progestin with glucocorticoid activity, used in the treatment of endometriosis, mastodynia (breast pain), and uterine fibroids. It is also used as a component of hormonal contraceptives to prevent pregnancy. Promegestone works by binding to progesterone receptors in the body, which helps regulate the menstrual cycle and prevent ovulation.

It's important to note that promegestone should only be used under the supervision of a healthcare provider, as it can have side effects and may interact with other medications.

Medroxyprogesterone Acetate (MPA) is a synthetic form of the natural hormone progesterone, which is often used in various medical applications. It is a white to off-white crystalline powder, slightly soluble in water, and freely soluble in alcohol, chloroform, and methanol.

Medically, MPA is used as a prescription medication for several indications, including:

1. Contraception: As an oral contraceptive or injectable solution, it can prevent ovulation, thicken cervical mucus to make it harder for sperm to reach the egg, and alter the lining of the uterus to make it less likely for a fertilized egg to implant.
2. Hormone replacement therapy (HRT): In postmenopausal women, MPA can help manage symptoms associated with decreased estrogen levels, such as hot flashes and vaginal dryness. It may also help prevent bone loss (osteoporosis).
3. Endometrial hyperplasia: MPA can be used to treat endometrial hyperplasia, a condition where the lining of the uterus becomes too thick, which could potentially lead to cancer if left untreated. By opposing the effects of estrogen, MPA helps regulate the growth of the endometrium.
4. Gynecological disorders: MPA can be used to treat various gynecological disorders, such as irregular menstrual cycles, amenorrhea (absence of menstruation), and dysfunctional uterine bleeding.
5. Cancer treatment: In some cases, MPA may be used in conjunction with other medications to treat certain types of breast or endometrial cancer.

As with any medication, Medroxyprogesterone Acetate can have side effects and potential risks. It is essential to consult a healthcare professional for proper evaluation, dosage, and monitoring when considering this medication.

Norethindrone is a synthetic form of progesterone, a female hormone that is produced naturally in the ovaries. It is used as a medication for various purposes such as:

* Preventing pregnancy when used as a birth control pill
* Treating endometriosis
* Managing symptoms associated with menopause
* Treating abnormal menstrual bleeding

Norethindrone works by thinning the lining of the uterus, preventing ovulation (the release of an egg from the ovary), and changing the cervical mucus to make it harder for sperm to reach the egg. It is important to note that norethindrone should be taken under the supervision of a healthcare provider, as it can have side effects and may interact with other medications.

Estrogen Replacement Therapy (ERT) is a medical treatment in which estrogen hormones are administered to replace the estrogen that is naturally produced by the ovaries but declines, especially during menopause. This therapy is often used to help manage symptoms of menopause such as hot flashes, night sweats, and vaginal dryness. It can also help prevent bone loss in postmenopausal women. ERT typically involves the use of estrogen alone, but in some cases, a combination of estrogen and progestin may be prescribed for women with a uterus to reduce the risk of endometrial cancer. However, ERT is associated with certain risks, including an increased risk of breast cancer, blood clots, and stroke, so it's important for women to discuss the potential benefits and risks with their healthcare provider before starting this therapy.

Progesterone receptors (PRs) are a type of nuclear receptor proteins that are expressed in the nucleus of certain cells and play a crucial role in the regulation of various physiological processes, including the menstrual cycle, embryo implantation, and maintenance of pregnancy. These receptors bind to the steroid hormone progesterone, which is produced primarily in the ovaries during the second half of the menstrual cycle and during pregnancy.

Once progesterone binds to the PRs, it triggers a series of molecular events that lead to changes in gene expression, ultimately resulting in the modulation of various cellular functions. Progesterone receptors exist in two main isoforms, PR-A and PR-B, which differ in their size, structure, and transcriptional activity. Both isoforms are expressed in a variety of tissues, including the female reproductive tract, breast, brain, and bone.

Abnormalities in progesterone receptor expression or function have been implicated in several pathological conditions, such as uterine fibroids, endometriosis, breast cancer, and osteoporosis. Therefore, understanding the molecular mechanisms underlying PR signaling is essential for developing novel therapeutic strategies to treat these disorders.

Medroxyprogesterone is a synthetic form of the natural hormone progesterone, which is a female sex hormone produced by the corpus luteum during the menstrual cycle and by the placenta during pregnancy. As a medication, medroxyprogesterone is used to treat a variety of conditions, including:

* Abnormal menstrual bleeding
* Endometrial hyperplasia (overgrowth of the lining of the uterus)
* Contraception (birth control)
* Hormone replacement therapy in postmenopausal women
* Prevention of breast cancer in high-risk women
* Treatment of certain types of cancer, such as endometrial and renal cancers

Medroxyprogesterone works by binding to progesterone receptors in the body, which helps to regulate the menstrual cycle, maintain pregnancy, and prevent the growth of some types of cancer. It is available in various forms, including tablets, injectable solutions, and depot suspensions for intramuscular injection.

It's important to note that medroxyprogesterone can have significant side effects, and its use should be monitored by a healthcare provider. Women who are pregnant or breastfeeding should not take medroxyprogesterone, and it may interact with other medications, so it is important to inform your doctor of all medications you are taking before starting medroxyprogesterone.

**Norgestrel** is a synthetic form of the naturally occurring hormone **progesterone**. It is a type of **progestin**, which is often used in various forms of hormonal birth control to prevent pregnancy. Norgestrel works by thickening cervical mucus, making it more difficult for sperm to reach and fertilize an egg. Additionally, norgestrel can also prevent ovulation (the release of an egg from the ovaries) and thin the lining of the uterus, which makes it less likely for a fertilized egg to implant.

Norgestrel is available in various forms, such as oral contraceptive pills, emergency contraceptives, and hormonal intrauterine devices (IUDs). It's essential to consult with a healthcare provider before starting any hormonal birth control method to discuss potential benefits, risks, and side effects.

Here are some medical definitions related to norgestrel:

1. **Progestin**: A synthetic form of the naturally occurring hormone progesterone, used in various forms of hormonal birth control and menopausal hormone therapy. Progestins can have varying levels of androgenic, estrogenic, and anti-estrogenic activity. Norgestrel is a type of progestin.
2. **Progesterone**: A naturally occurring steroid hormone produced by the ovaries during the second half of the menstrual cycle. Progesterone plays a crucial role in preparing the uterus for pregnancy and maintaining a healthy pregnancy. Norgestrel is a synthetic form of progesterone.
3. **Hormonal birth control**: A method of preventing pregnancy that uses hormones to regulate ovulation, thicken cervical mucus, or thin the lining of the uterus. Hormonal birth control methods include oral contraceptive pills, patches, rings, injections, implants, and intrauterine devices (IUDs).
4. **Emergency contraception**: A form of hormonal birth control used to prevent pregnancy after unprotected sex or contraceptive failure. Emergency contraception is typically more effective when taken as soon as possible after unprotected intercourse, but it can still be effective up to 120 hours afterward. Norgestrel is one of the active ingredients in some emergency contraceptive pills.
5. **Menopausal hormone therapy (MHT)**: A form of hormone replacement therapy used to alleviate symptoms associated with menopause, such as hot flashes and vaginal dryness. MHT typically involves using estrogen and progestin or a selective estrogen receptor modulator (SERM). Norgestrel is a type of progestin that can be used in MHT.
6. **Androgenic**: Describing the effects of hormones, such as testosterone and some progestins, that are associated with male characteristics, such as facial hair growth, deepening of the voice, and increased muscle mass. Norgestrel has weak androgenic activity.
7. **Estrogenic**: Describing the effects of hormones, such as estradiol and some selective estrogen receptor modulators (SERMs), that are associated with female characteristics, such as breast development and menstrual cycles. Norgestrel has weak estrogenic activity.
8. **Antiestrogenic**: Describing the effects of hormones or drugs that block or oppose the actions of estrogens. Norgestrel has antiestrogenic activity.
9. **Selective estrogen receptor modulator (SERM)**: A type of drug that acts as an estrogen agonist in some tissues and an estrogen antagonist in others. SERMs can be used to treat or prevent breast cancer, osteoporosis, and other conditions associated with hormonal imbalances. Norgestrel is not a SERM but has antiestrogenic activity.
10. **Progestogen**: A synthetic or natural hormone that has progesterone-like effects on the body. Progestogens can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and irregular menstrual cycles. Norgestrel is a type of progestogen.
11. **Progesterone**: A natural hormone produced by the ovaries during the second half of the menstrual cycle. Progesterone prepares the uterus for pregnancy and regulates the menstrual cycle. Norgestrel is a synthetic form of progesterone.
12. **Progestin**: A synthetic hormone that has progesterone-like effects on the body. Progestins can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and irregular menstrual cycles. Norgestrel is a type of progestin.
13. **Progestational agent**: A drug or hormone that has progesterone-like effects on the body. Progestational agents can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and irregular menstrual cycles. Norgestrel is a type of progestational agent.
14. **Progestogenic**: Describing the effects of hormones or drugs that mimic or enhance the actions of progesterone. Norgestrel has progestogenic activity.
15. **Progesterone receptor modulator (PRM)**: A type of drug that binds to and activates or inhibits the progesterone receptors in the body. PRMs can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is a type of PRM.
16. **Progestogenic activity**: The ability of a drug or hormone to mimic or enhance the actions of progesterone in the body. Norgestrel has progestogenic activity.
17. **Progesterone antagonist**: A drug that blocks the action of progesterone in the body. Progesterone antagonists can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is not a progesterone antagonist.
18. **Progestogenic antagonist**: A drug that blocks the action of progestogens in the body. Progestogenic antagonists can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is not a progesterone antagonist.
19. **Progesterone agonist**: A drug that enhances the action of progesterone in the body. Progesterone agonists can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is a progesterone agonist.
20. **Progestogenic agonist**: A drug that enhances the action of progestogens in the body. Progesterogenic agonists can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is a progesterone agonist.
21. **Progesterone receptor modulator**: A drug that binds to the progesterone receptor and can either activate or inhibit its activity. Progesterone receptor modulators can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is a progesterone receptor modulator.
22. **Progestogenic receptor modulator**: A drug that binds to the progesterone receptor and can either activate or inhibit its activity. Progesterogenic receptor modulators can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is a progesterone receptor modulator.
23. **Progestin**: A synthetic form of progesterone that is used in hormonal contraceptives and menopausal hormone therapy. Progestins can be either progesterone agonists or antagonists, depending on their chemical structure and activity at the progesterone receptor. Norgestrel is a progestin.
24. **Progesterone antagonist**: A drug that binds to the progesterone receptor and inhibits its activity. Progesterone antagonists can be used to treat various medical conditions, such as endometriosis, uterine fibroids, and breast cancer. Norgestrel is not a progesterone antagonist.
25. **Progestogenic antagonist**: A drug that binds to the progesterone receptor and inhibits its activity. Progesterogenic antagonists can be used to treat various medical conditions, such as endometriosis, uterine fibro

Norpregnadienes are a type of steroid hormone that are structurally similar to progesterone, but with certain chemical groups (such as the methyl group at C10) removed. They are formed through the metabolism of certain steroid hormones and can be further metabolized into other compounds.

Norpregnadienes have been studied for their potential role in various physiological processes, including the regulation of reproductive function and the development of certain diseases such as cancer. However, more research is needed to fully understand their functions and clinical significance.

I believe there may be some confusion in your question as "Norprogesterones" is not a recognized term in medical terminology. However, I can provide you with information on "Progestogens" or "Progestins," which are often referred to as "norpregnenolone derivatives."

Progestogens/Progestins are a class of steroid hormones that are similar to progesterone, a natural hormone produced in the ovaries and placenta during pregnancy. They share many of the same functions as progesterone, including preparing the uterus for implantation of a fertilized egg, maintaining the lining of the uterus during pregnancy, and supporting lactation after childbirth.

Progestogens/Progestins are used in various medical applications, such as hormonal contraceptives, menopausal hormone therapy, and treatment for gynecological disorders like endometriosis or abnormal uterine bleeding. They can be synthesized from other steroid hormones, including progesterone, testosterone, and cortisol.

Some examples of progestogens/progestins include:

* Norethisterone (norethindrone)
* Levonorgestrel
* Medroxyprogesterone acetate
* Dydrogesterone
* Gestodene
* Norgestimate

If you meant to ask about a specific progestogen or progestin, please let me know and I can provide more information on that particular compound.

Levonorgestrel is a synthetic form of the natural hormone progesterone, which is used in various forms of birth control and emergency contraceptives. It works by preventing ovulation (the release of an egg from the ovaries), thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant.

Medically, Levonorgestrel is classified as a progestin and is available in various forms, including oral tablets, intrauterine devices (IUDs), and emergency contraceptive pills. It may also be used to treat endometriosis, irregular menstrual cycles, and heavy menstrual bleeding.

It's important to note that while Levonorgestrel is a highly effective form of birth control when used correctly, it does not protect against sexually transmitted infections (STIs). Therefore, condoms should still be used during sexual activity if there is any risk of STI transmission.

Progesterone is a steroid hormone that is primarily produced in the ovaries during the menstrual cycle and in pregnancy. It plays an essential role in preparing the uterus for implantation of a fertilized egg and maintaining the early stages of pregnancy. Progesterone works to thicken the lining of the uterus, creating a nurturing environment for the developing embryo.

During the menstrual cycle, progesterone is produced by the corpus luteum, a temporary structure formed in the ovary after an egg has been released from a follicle during ovulation. If pregnancy does not occur, the levels of progesterone will decrease, leading to the shedding of the uterine lining and menstruation.

In addition to its reproductive functions, progesterone also has various other effects on the body, such as helping to regulate the immune system, supporting bone health, and potentially influencing mood and cognition. Progesterone can be administered medically in the form of oral pills, intramuscular injections, or vaginal suppositories for various purposes, including hormone replacement therapy, contraception, and managing certain gynecological conditions.

Pregnenediones are a class of steroid hormones that contain a pregnane structure, which is a skeleton formed by four fused cyclohexane rings. Specifically, pregnenediones are characterized by having a ketone group (a carbonyl group, -C=O) at the 20th carbon position of this pregnane structure. They can be further classified into various subgroups based on the presence and location of other functional groups in the molecule.

Pregnenediones are not typically used as medications, but they do play important roles in the human body. For example, progesterone is a naturally occurring pregnenedione that plays a crucial role in maintaining pregnancy and preparing the uterus for childbirth. Other pregnenediones may also have hormonal activity or serve as intermediates in the synthesis of other steroid hormones.

Estrogens are a group of steroid hormones that are primarily responsible for the development and regulation of female sexual characteristics and reproductive functions. They are also present in lower levels in males. The main estrogen hormone is estradiol, which plays a key role in promoting the growth and development of the female reproductive system, including the uterus, fallopian tubes, and breasts. Estrogens also help regulate the menstrual cycle, maintain bone density, and have important effects on the cardiovascular system, skin, hair, and cognitive function.

Estrogens are produced primarily by the ovaries in women, but they can also be produced in smaller amounts by the adrenal glands and fat cells. In men, estrogens are produced from the conversion of testosterone, the primary male sex hormone, through a process called aromatization.

Estrogen levels vary throughout a woman's life, with higher levels during reproductive years and lower levels after menopause. Estrogen therapy is sometimes used to treat symptoms of menopause, such as hot flashes and vaginal dryness, or to prevent osteoporosis in postmenopausal women. However, estrogen therapy also carries risks, including an increased risk of certain cancers, blood clots, and stroke, so it is typically recommended only for women who have a high risk of these conditions.

Desogestrel is a synthetic form of progestin, which is a female sex hormone. It is used in various forms of hormonal contraception such as birth control pills, patches, and vaginal rings to prevent pregnancy. Desogestrel works by preventing ovulation (the release of an egg from the ovaries), thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant.

Desogestrel is also used in some hormone replacement therapies (HRT) to treat symptoms of menopause such as hot flashes and vaginal dryness. It may be prescribed alone or in combination with estrogen.

Like all hormonal contraceptives, desogestrel has potential side effects, including irregular menstrual bleeding, headaches, mood changes, breast tenderness, and nausea. In rare cases, it may also increase the risk of blood clots, stroke, or heart attack. It is important to discuss the risks and benefits of desogestrel with a healthcare provider before using it.

Norpregnenes are a class of steroids that are produced by the metabolism of progesterone and other pregnanes. They are characterized by the absence of a double bond between carbons 4 and 5, and the presence of a ketone group at carbon 3. Some examples of norpregnenes include dehydroepiandrosterone (DHEA), androstenedione, and pregnenolone. These steroids are important intermediates in the biosynthesis of various hormones, including cortisol, aldosterone, androgens, and estrogens. They play a role in various physiological processes such as sexual development, immune function, and stress response.

Hydroxyprogesterone is a synthetic form of the natural hormone progesterone, which is produced by the body during pregnancy to support the growth and development of the fetus. Hydroxyprogesterone is used in medical treatments to help prevent preterm birth in certain high-risk pregnancies.

There are several different forms of hydroxyprogesterone that have been developed for use as medications, including:

1. Hydroxyprogesterone caproate (HPC): This is a synthetic form of progesterone that is given as an injection once a week to help prevent preterm birth in women who have previously given birth prematurely. It works by helping to thicken the lining of the uterus and prevent contractions.
2. 17-Hydroxyprogesterone: This is a natural hormone that is produced by the body during pregnancy, but it can also be synthesized in a laboratory for use as a medication. It has been studied for its potential to help prevent preterm birth, although it is not currently approved for this use by the U.S. Food and Drug Administration (FDA).
3. 21-Hydroxyprogesterone: This is another natural hormone that is produced by the body during pregnancy, but it can also be synthesized in a laboratory for use as a medication. It has been studied for its potential to help prevent preterm birth and for its ability to reduce the risk of certain complications in women with a history of premature birth.

It's important to note that hydroxyprogesterone should only be used under the supervision of a healthcare provider, as it can have side effects and may not be appropriate for all women. If you are pregnant or planning to become pregnant and have concerns about preterm birth, it's important to discuss your options with your healthcare provider.

Oral contraceptives, also known as "birth control pills," are synthetic hormonal medications that are taken by mouth to prevent pregnancy. They typically contain a combination of synthetic versions of the female hormones estrogen and progesterone, which work together to inhibit ovulation (the release of an egg from the ovaries), thicken cervical mucus (making it harder for sperm to reach the egg), and thin the lining of the uterus (making it less likely that a fertilized egg will implant).

There are several different types of oral contraceptives, including combination pills, progestin-only pills, and extended-cycle pills. Combination pills contain both estrogen and progestin, while progestin-only pills contain only progestin. Extended-cycle pills are a type of combination pill that are taken for 12 weeks followed by one week of placebo pills, which can help reduce the frequency of menstrual periods.

It's important to note that oral contraceptives do not protect against sexually transmitted infections (STIs), so it's still important to use barrier methods like condoms if you are at risk for STIs. Additionally, oral contraceptives can have side effects and may not be suitable for everyone, so it's important to talk to your healthcare provider about the potential risks and benefits before starting to take them.

Oral combined contraceptives, also known as "the pill," are a type of hormonal birth control that contain a combination of synthetic estrogen and progestin. These hormones work together to prevent ovulation (the release of an egg from the ovaries), thicken cervical mucus to make it harder for sperm to reach the egg, and thin the lining of the uterus to make it less likely for a fertilized egg to implant.

Combined oral contraceptives come in various brands and forms, such as monophasic, biphasic, and triphasic pills. Monophasic pills contain the same amount of hormones in each active pill, while biphasic and triphasic pills have varying amounts of hormones in different phases of the cycle.

It is important to note that oral combined contraceptives do not protect against sexually transmitted infections (STIs) and should be used in conjunction with condoms for safer sex practices. Additionally, there are potential risks and side effects associated with oral combined contraceptives, including an increased risk of blood clots, stroke, and heart attack, especially in women who smoke or have certain medical conditions. It is essential to consult a healthcare provider before starting any hormonal birth control method to determine if it is safe and appropriate for individual use.

Mifepristone is a synthetic steroid that is used in the medical termination of pregnancy (also known as medication abortion or RU-486). It works by blocking the action of progesterone, a hormone necessary for maintaining pregnancy. Mifepristone is often used in combination with misoprostol to cause uterine contractions and expel the products of conception from the uterus.

It's also known as an antiprogestin or progesterone receptor modulator, which means it can bind to progesterone receptors in the body and block their activity. In addition to its use in pregnancy termination, mifepristone has been studied for its potential therapeutic uses in conditions such as Cushing's syndrome, endometriosis, uterine fibroids, and hormone-dependent cancers.

It is important to note that Mifepristone should be administered under the supervision of a licensed healthcare professional and it is not available over the counter. Also, it has some contraindications and potential side effects, so it's essential to have a consultation with a doctor before taking this medication.

Estradiol is a type of estrogen, which is a female sex hormone. It is the most potent and dominant form of estrogen in humans. Estradiol plays a crucial role in the development and maintenance of secondary sexual characteristics in women, such as breast development and regulation of the menstrual cycle. It also helps maintain bone density, protect the lining of the uterus, and is involved in cognition and mood regulation.

Estradiol is produced primarily by the ovaries, but it can also be synthesized in smaller amounts by the adrenal glands and fat cells. In men, estradiol is produced from testosterone through a process called aromatization. Abnormal levels of estradiol can contribute to various health issues, such as hormonal imbalances, infertility, osteoporosis, and certain types of cancer.

20-Alpha-Dihydroprogesterone is a weak endogenous progestin, a form of progesterone, naturally occurring in the body. It is a metabolite of progesterone and has only about 1% of the activity of its parent compound. It is formed by the action of the enzyme 5-alpha-reductase on progesterone.

Medical Definition:
20-Alpha-Dihydroprogesterone (20-α-DHP): An endogenous progestin, a weak metabolite of progesterone, formed by the action of 5-alpha-reductase on progesterone. It has only about 1% of the activity of its parent compound, progesterone.

Norethynodrel is a synthetic progestin, which is a type of female sex hormone. It is not commonly used in modern medicine. In the past, it was used in some oral contraceptives to prevent pregnancy by inhibiting ovulation and altering the cervical mucus and endometrium. Norethynodrel is no longer widely used due to the development of newer and more effective progestins.

Hormone Replacement Therapy (HRT) is a medical treatment that involves the use of hormones to replace or supplement those that the body is no longer producing or no longer producing in sufficient quantities. It is most commonly used to help manage symptoms associated with menopause and conditions related to hormonal imbalances.

In women, HRT typically involves the use of estrogen and/or progesterone to alleviate hot flashes, night sweats, vaginal dryness, and mood changes that can occur during menopause. In some cases, testosterone may also be prescribed to help improve energy levels, sex drive, and overall sense of well-being.

In men, HRT is often used to treat low testosterone levels (hypogonadism) and related symptoms such as fatigue, decreased muscle mass, and reduced sex drive.

It's important to note that while HRT can be effective in managing certain symptoms, it also carries potential risks, including an increased risk of blood clots, stroke, breast cancer (in women), and cardiovascular disease. Therefore, the decision to undergo HRT should be made carefully and discussed thoroughly with a healthcare provider.

5-Alpha-Dihydroprogesterone, also known as 5α-DHP, is a metabolite of progesterone. It is formed in the body by the action of the enzyme 5-alpha-reductase on progesterone. 5-Alpha-Dihydroprogesterone is a weak androgen and has been found to have some effects on the development and maintenance of male sexual characteristics. It may also play a role in the regulation of the menstrual cycle in women. However, its precise physiological functions are not fully understood.

Contraceptive agents, female, are medications or devices specifically designed to prevent pregnancy in women. They work by interfering with the normal process of ovulation, fertilization, or implantation of a fertilized egg in the uterus. Some common examples of female contraceptive agents include:

1. Hormonal methods: These include combined oral contraceptives (COCs), progestin-only pills, patches, vaginal rings, and hormonal implants. They contain synthetic forms of the female hormones estrogen and/or progesterone, which work by preventing ovulation, thickening cervical mucus to make it harder for sperm to reach the egg, or thinning the lining of the uterus to prevent implantation of a fertilized egg.
2. Intrauterine devices (IUDs): These are small, T-shaped devices made of plastic or copper that are inserted into the uterus by a healthcare provider. They release hormones or copper ions that interfere with sperm movement and prevent fertilization or implantation.
3. Barrier methods: These include condoms, diaphragms, cervical caps, and sponges. They work by physically preventing sperm from reaching the egg.
4. Emergency contraception: This includes medications such as Plan B or Ella, which can be taken up to 5 days after unprotected sex to prevent pregnancy. They work by delaying ovulation or preventing fertilization of the egg.
5. Fertility awareness-based methods (FABMs): These involve tracking a woman's menstrual cycle and avoiding sexual intercourse during her fertile window. Some FABMs also involve using barrier methods during this time.

It is important to note that different contraceptive agents have varying levels of effectiveness, side effects, and risks. Women should consult with their healthcare provider to determine the best method for their individual needs and circumstances.

Endometrial hyperplasia is a condition in which the lining of the uterus (endometrium) becomes thickened due to an overgrowth of cells. This occurs as a result of excessive estrogen stimulation without adequate progesterone to balance it. The thickening of the endometrium can range from mild to severe, and in some cases, it may lead to the development of abnormal or precancerous cells.

There are different types of endometrial hyperplasia, including simple hyperplasia, complex hyperplasia, and atypical hyperplasia. Simple hyperplasia has an increased number of glands but no significant architectural distortion, while complex hyperplasia shows crowded glands with architectural complexity. Atypical hyperplasia is a more serious condition characterized by the presence of abnormal cells, which can increase the risk of developing endometrial cancer if left untreated.

The primary symptoms of endometrial hyperplasia include irregular menstrual periods, heavy or prolonged bleeding, and postmenopausal bleeding. The diagnosis typically involves a transvaginal ultrasound and an endometrial biopsy to evaluate the tissue sample for cell changes. Treatment options depend on the type and severity of hyperplasia, as well as the patient's age and overall health. Hormonal therapy, progestin-based medications, or a hysterectomy (surgical removal of the uterus) may be recommended to manage this condition.

Megestrol is a synthetic progestin, which is a type of female hormone. It is used to treat certain types of cancer, such as breast cancer and endometrial cancer, in postmenopausal women. Megestrol works by blocking the effects of estrogen, a female hormone that can promote the growth of some breast and endometrial cancers.

Megestrol is also used to treat anorexia (loss of appetite) and cachexia (wasting syndrome) in people with AIDS or cancer. It works by increasing appetite and promoting weight gain.

Megestrol is available as a tablet or a suspension that is taken by mouth, usually two to four times a day. The dosage depends on the condition being treated and the individual patient's response to therapy. Common side effects of megestrol include nausea, vomiting, diarrhea, dizziness, headache, breast tenderness, and changes in menstrual periods.

It is important to note that megestrol can cause serious side effects, such as blood clots, fluid retention, and increased risk of certain types of infections. Patients should discuss the risks and benefits of megestrol therapy with their healthcare provider before starting treatment.

Oral hormonal contraceptives, also known as "birth control pills," are a type of medication that contains synthetic hormones (estrogen and/or progestin) that are taken by mouth to prevent pregnancy. They work by preventing ovulation (the release of an egg from the ovaries), thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant.

There are several different types of oral hormonal contraceptives, including combined pills that contain both estrogen and progestin, and mini-pills that only contain progestin. These medications are usually taken daily for 21 days, followed by a seven-day break during which menstruation occurs. Some newer formulations may be taken continuously with no break.

It's important to note that while oral hormonal contraceptives are highly effective at preventing pregnancy when used correctly, they do not protect against sexually transmitted infections (STIs). Therefore, it is still important to use barrier methods of protection, such as condoms, during sexual activity to reduce the risk of STIs.

As with any medication, oral hormonal contraceptives can have side effects and may not be suitable for everyone. It's important to discuss any medical conditions, allergies, or medications you are taking with your healthcare provider before starting to take oral hormonal contraceptives.

An intrauterine device (IUD) is a small, T-shaped birth control device that is inserted into the uterus to prevent pregnancy. A medicated IUD is a type of IUD that contains hormones, which are released slowly over time to provide additional benefits beyond just contraception.

There are two types of medicated IUDs available in the US market: levonorgestrel-releasing intrauterine system (LNG-IUS) and the copper intrauterine device (Cu-IUD). The LNG-IUS releases a progestin hormone called levonorgestrel, which thickens cervical mucus to prevent sperm from reaching the egg, thins the lining of the uterus to make it less likely for a fertilized egg to implant, and can also inhibit ovulation in some women. The Cu-IUD is non-hormonal and works by releasing copper ions that create a toxic environment for sperm, preventing them from reaching the egg.

Medicated IUDs are highly effective at preventing pregnancy, with typical use failure rates of less than 1% per year. They can remain in place for several years, depending on the brand, and can be removed at any time by a healthcare provider if a woman wants to become pregnant or experience side effects. Common side effects of medicated IUDs may include irregular menstrual bleeding, cramping, and spotting between periods, although these tend to improve over time.

Oral contraceptives, also known as "birth control pills," are medications taken by mouth to prevent pregnancy. They contain synthetic hormones that mimic the effects of natural hormones estrogen and progesterone in a woman's body, thereby preventing ovulation, fertilization, or implantation of a fertilized egg in the uterus.

There are two main types of oral contraceptives: combined pills, which contain both estrogen and progestin, and mini-pills, which contain only progestin. Combined pills work by preventing ovulation, thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant. Mini-pills work mainly by thickening cervical mucus and changing the lining of the uterus.

Oral contraceptives are highly effective when used correctly, but they do not protect against sexually transmitted infections (STIs). It is important to use them consistently and as directed by a healthcare provider. Side effects may include nausea, breast tenderness, headaches, mood changes, and irregular menstrual bleeding. In rare cases, oral contraceptives may increase the risk of serious health problems such as blood clots, stroke, or liver tumors. However, for most women, the benefits of using oral contraceptives outweigh the risks.

Ethinyl estradiol is a synthetic form of the hormone estrogen that is often used in various forms of hormonal contraception, such as birth control pills. It works by preventing ovulation and thickening cervical mucus to make it more difficult for sperm to reach the egg. Ethinyl estradiol may also be used in combination with other hormones to treat menopausal symptoms or hormonal disorders.

It is important to note that while ethinyl estradiol can be an effective form of hormonal therapy, it can also carry risks and side effects, such as an increased risk of blood clots, stroke, and breast cancer. As with any medication, it should only be used under the guidance and supervision of a healthcare provider.

Lynestrenol is a synthetic form of progestogen, which is a female sex hormone. It is used in various medications for different purposes, such as treating abnormal menstrual bleeding, endometriosis, and preventing premature labor. Lynestrenol works by mimicking the effects of natural progesterone in the body, helping to regulate the menstrual cycle and reduce inflammation associated with endometriosis. It is important to note that lynestrenol should only be used under the supervision of a healthcare professional, as it can have side effects and interact with other medications.

Postmenopause is a stage in a woman's life that follows 12 months after her last menstrual period (menopause) has occurred. During this stage, the ovaries no longer release eggs and produce lower levels of estrogen and progesterone hormones. The reduced levels of these hormones can lead to various physical changes and symptoms, such as hot flashes, vaginal dryness, and mood changes. Postmenopause is also associated with an increased risk of certain health conditions, including osteoporosis and heart disease. It's important for women in postmenopause to maintain a healthy lifestyle, including regular exercise, a balanced diet, and routine medical check-ups to monitor their overall health and manage any potential risks.

The endometrium is the innermost layer of the uterus, which lines the uterine cavity and has a critical role in the menstrual cycle and pregnancy. It is composed of glands and blood vessels that undergo cyclic changes under the influence of hormones, primarily estrogen and progesterone. During the menstrual cycle, the endometrium thickens in preparation for a potential pregnancy. If fertilization does not occur, it will break down and be shed, resulting in menstruation. In contrast, if implantation takes place, the endometrium provides essential nutrients to support the developing embryo and placenta throughout pregnancy.

Dydrogesterone is a synthetic form of the natural hormone progesterone, which is used in various forms of medical therapy. It is primarily used as a hormonal supplement during infertility treatments and to prevent pregnancy loss in women with a history of miscarriage due to progesterone deficiency.

Dydrogesterone works by mimicking the effects of natural progesterone, which helps to prepare the lining of the uterus for implantation of a fertilized egg and supports the early stages of pregnancy. It is also used in the treatment of endometriosis, a condition where tissue similar to the lining of the uterus grows outside of it, causing pain and other symptoms.

Dydrogesterone is available in various forms, including tablets and capsules, and is typically taken orally. The dosage and duration of treatment may vary depending on the specific medical condition being treated and the individual patient's needs. As with any medication, dydrogesterone should only be used under the guidance and supervision of a qualified healthcare provider.

Androstenes are a group of steroidal compounds that are produced and released by the human body. They are classified as steroids because they contain a characteristic carbon skeleton, called the sterane ring, which consists of four fused rings arranged in a specific structure. Androstenes are derived from cholesterol and are synthesized in the gonads (testes and ovaries), adrenal glands, and other tissues.

The term "androstene" refers specifically to compounds that contain a double bond between the 5th and 6th carbon atoms in the sterane ring. This double bond gives these compounds their characteristic chemical properties and distinguishes them from other steroidal compounds.

Androstenes are important in human physiology because they serve as precursors to the synthesis of sex hormones, such as testosterone and estrogen. They also have been found to play a role in the regulation of various bodily functions, including sexual behavior, mood, and cognition.

Some examples of androstenes include androstenedione, which is a precursor to both testosterone and estrogen; androstenediol, which can be converted into either testosterone or estrogen; and androsterone, which is a weak androgen that is produced in the body as a metabolite of testosterone.

It's worth noting that androstenes are sometimes referred to as "pheromones" because they have been found to play a role in chemical communication between individuals of the same species. However, this use of the term "pheromone" is controversial and not universally accepted, as it has been difficult to demonstrate conclusively that humans communicate using chemical signals in the same way that many other animals do.

Chlormadinone Acetate is a synthetic progestin, which is a type of female sex hormone. It is used in the treatment of various medical conditions such as endometriosis, uterine fibroids, and abnormal menstrual bleeding. It works by suppressing the natural progesterone produced by the ovaries, thereby preventing the buildup of the lining of the uterus (endometrium). This medication is available in the form of tablets for oral administration.

It's important to note that Chlormadinone Acetate can cause a range of side effects and should only be used under the supervision of a healthcare provider. Additionally, it may interact with other medications, so it's important to inform your doctor about all the medications you are taking before starting this medication.

Cyproterone acetate is a synthetic steroid hormone with anti-androgen and progestogenic properties. It works by blocking the action of androgens (male sex hormones) in the body, which helps to reduce symptoms associated with excessive androgen production such as severe acne or hirsutism (excessive hair growth).

Cyproterone acetate is used in the treatment of conditions such as prostate cancer, where it can help to slow the growth of cancer cells by reducing the levels of androgens in the body. It is also used in the treatment of sexual deviations, such as pedophilia or exhibitionism, as it can reduce sexual desire.

In addition, cyproterone acetate is sometimes used in combination with estrogen in hormone replacement therapy for transgender women to suppress the production of testosterone and promote feminization.

It's important to note that cyproterone acetate can have significant side effects and its use should be under the close supervision of a healthcare professional.

A drug implant is a medical device that is specially designed to provide controlled release of a medication into the body over an extended period of time. Drug implants can be placed under the skin or in various body cavities, depending on the specific medical condition being treated. They are often used when other methods of administering medication, such as oral pills or injections, are not effective or practical.

Drug implants come in various forms, including rods, pellets, and small capsules. The medication is contained within the device and is released slowly over time, either through diffusion or erosion of the implant material. This allows for a steady concentration of the drug to be maintained in the body, which can help to improve treatment outcomes and reduce side effects.

Some common examples of drug implants include:

1. Hormonal implants: These are small rods that are inserted under the skin of the upper arm and release hormones such as progestin or estrogen over a period of several years. They are often used for birth control or to treat conditions such as endometriosis or uterine fibroids.
2. Intraocular implants: These are small devices that are placed in the eye during surgery to release medication directly into the eye. They are often used to treat conditions such as age-related macular degeneration or diabetic retinopathy.
3. Bone cement implants: These are specially formulated cements that contain antibiotics and are used to fill bone defects or joint spaces during surgery. The antibiotics are released slowly over time, helping to prevent infection.
4. Implantable pumps: These are small devices that are placed under the skin and deliver medication directly into a specific body cavity, such as the spinal cord or the peritoneal cavity. They are often used to treat chronic pain or cancer.

Overall, drug implants offer several advantages over other methods of administering medication, including improved compliance, reduced side effects, and more consistent drug levels in the body. However, they may also have some disadvantages, such as the need for surgical placement and the potential for infection or other complications. As with any medical treatment, it is important to discuss the risks and benefits of drug implants with a healthcare provider.

Melengestrol Acetate (MGA) is a synthetic progestin, which is a type of steroid hormone. It is used primarily as a growth promoter in the livestock industry to increase weight gain and feed efficiency in beef cattle. MGA works by suppressing the animal's natural hormonal balance, particularly the levels of estrogen and testosterone, which leads to changes in metabolism and behavior that promote weight gain.

It is not approved for use in humans in many countries, including the United States, due to concerns about potential health risks associated with its long-term use, such as reproductive and developmental effects. However, it has been used off-label in some cases to treat certain medical conditions in women, such as endometriosis or abnormal uterine bleeding, under the close supervision of a healthcare provider.

Megestrol acetate is a synthetic progestin, which is a hormone that acts like progesterone in the body. It is used to treat various conditions such as endometrial cancer, breast cancer, and anorexia associated with AIDS. It works by blocking the action of certain hormones in the body, which can slow or stop the growth of some types of cancer cells. In addition, megestrol acetate can help increase appetite and weight gain in people with HIV/AIDS.

The medication is available in various forms, including tablets and oral suspension, and its use should be under the supervision of a healthcare professional who will determine the appropriate dosage based on the patient's medical condition and response to treatment. Common side effects of megestrol acetate include nausea, vomiting, diarrhea, gas, headache, dizziness, and changes in mood or sex drive.

20-Hydroxysteroid Dehydrogenases (20-HSDs) are a group of enzymes that play a crucial role in the metabolism of steroid hormones. These enzymes catalyze the conversion of steroid hormone precursors to their active forms by adding or removing a hydroxyl group at the 20th carbon position of the steroid molecule.

There are several isoforms of 20-HSDs, each with distinct tissue distribution and substrate specificity. The most well-known isoforms include 20-HSD type I and II, which have opposing functions in regulating the activity of cortisol, a glucocorticoid hormone produced by the adrenal gland.

Type I 20-HSD, primarily found in the liver and adipose tissue, converts inactive cortisone to its active form, cortisol. In contrast, type II 20-HSD, expressed mainly in the kidney, brain, and immune cells, catalyzes the reverse reaction, converting cortisol back to cortisone.

Dysregulation of 20-HSDs has been implicated in various medical conditions, such as metabolic disorders, inflammatory diseases, and cancers. Therefore, understanding the function and regulation of these enzymes is essential for developing targeted therapies for these conditions.

Endometrial neoplasms refer to abnormal growths or tumors in the endometrium, which is the innermost lining of the uterus. These neoplasms can be benign (non-cancerous) or malignant (cancerous). The two main types of endometrial cancer are type I, also known as endometrioid adenocarcinoma, and type II, which includes serous carcinoma, clear cell carcinoma, and carcinosarcoma.

Type I endometrial cancers are usually estrogen-dependent and associated with risk factors such as obesity, diabetes, and prolonged exposure to estrogen without progesterone. They tend to grow more slowly and have a better prognosis than type II cancers.

Type II endometrial cancers are less common but more aggressive, often presenting at an advanced stage and having a worse prognosis. They are not typically associated with hormonal factors and may occur in women who have gone through menopause.

Endometrial neoplasms can also include benign growths such as polyps, hyperplasia, and endometriosis. While these conditions are not cancerous, they can increase the risk of developing endometrial cancer and should be monitored closely by a healthcare provider.

Menopause is a natural biological process that typically occurs in women in their mid-40s to mid-50s. It marks the end of menstrual cycles and fertility, defined as the absence of menstruation for 12 consecutive months. This transition period can last several years and is often accompanied by various physical and emotional symptoms such as hot flashes, night sweats, mood changes, sleep disturbances, and vaginal dryness. The hormonal fluctuations during this time, particularly the decrease in estrogen levels, contribute to these symptoms. It's essential to monitor and manage these symptoms to maintain overall health and well-being during this phase of life.

The climacteric, also known as perimenopause or menopausal transition, is a phase in a woman's reproductive life characterized by various physiological and hormonal changes that occur as she approaches menopause. The term "climacteric" comes from the Greek word "klimakter," which means "ladder" or "rung of a ladder."

During this phase, which typically begins in a woman's mid-to-late 40s and can last for several years, the production of estrogen and progesterone by the ovaries starts to decline. This decline in hormone levels can lead to a variety of symptoms, including:

* Irregular menstrual cycles
* Hot flashes and night sweats
* Sleep disturbances
* Mood changes
* Vaginal dryness and discomfort during sexual activity
* Decreased libido
* Urinary frequency or urgency
* Memory and cognitive changes

The climacteric is a natural phase of a woman's life, and while some women may experience significant symptoms, others may have few or no symptoms at all. Hormone replacement therapy (HRT) and other treatments are available to help manage the symptoms of the climacteric for those who find them disruptive or bothersome.

Nandrolone is a synthetic anabolic-androgenic steroid, which is a type of hormone that is similar to testosterone. It is often used in medical settings for the treatment of certain conditions such as muscle wasting diseases, osteoporosis, and breast cancer in women. Nandrolone promotes muscle growth and increases appetite, which can help individuals with muscle wasting diseases or other conditions that cause muscle loss to maintain their strength and weight.

Nandrolone is also known by its brand names Deca-Durabolin and Durabolin. It works by increasing the production of proteins in the body, which helps to build muscle mass. Nandrolone can have both anabolic (muscle-building) and androgenic (masculinizing) effects, although it is generally considered to be less androgenic than testosterone.

Like other anabolic steroids, nandrolone can have a number of side effects, including acne, hair loss, liver damage, and mood changes. It can also cause virilization in women, which refers to the development of male characteristics such as a deep voice, facial hair, and a decrease in breast size. Nandrolone is classified as a controlled substance in many countries due to its potential for abuse and dependence.

Uterine hemorrhage, also known as uterine bleeding or gynecological bleeding, is an abnormal loss of blood from the uterus. It can occur in various clinical settings such as menstruation (known as menorrhagia), postpartum period (postpartum hemorrhage), or in non-pregnant women (dysfunctional uterine bleeding). The bleeding may be light to heavy, intermittent or continuous, and can be accompanied by symptoms such as pain, dizziness, or fainting. Uterine hemorrhage is a common gynecological problem that can have various underlying causes, including hormonal imbalances, structural abnormalities, coagulopathies, and malignancies. It is important to seek medical attention if experiencing heavy or prolonged uterine bleeding to determine the cause and receive appropriate treatment.

Estrus synchronization is a veterinary medical procedure used in the management of domestic animals, such as cattle and sheep. It is a process of coordinating the estrous cycles of animals so that they can be bred at the same time or have their fertility treatments performed simultaneously. This is achieved through the use of various hormonal therapies, including progestins, prostaglandins, and gonadotropin-releasing hormones (GnRH).

The goal of estrus synchronization is to improve reproductive efficiency in animal production systems by ensuring that a larger number of animals become pregnant during a shorter breeding season. This can lead to more uniform calf or lamb crops, reduced labor and management costs, and increased profitability for farmers and ranchers.

Estrus synchronization is a complex process that requires careful planning and implementation, as well as ongoing monitoring and evaluation of the animals' reproductive performance. It is typically performed under the guidance of a veterinarian or animal reproduction specialist.

Breast neoplasms refer to abnormal growths in the breast tissue that can be benign or malignant. Benign breast neoplasms are non-cancerous tumors or growths, while malignant breast neoplasms are cancerous tumors that can invade surrounding tissues and spread to other parts of the body.

Breast neoplasms can arise from different types of cells in the breast, including milk ducts, milk sacs (lobules), or connective tissue. The most common type of breast cancer is ductal carcinoma, which starts in the milk ducts and can spread to other parts of the breast and nearby structures.

Breast neoplasms are usually detected through screening methods such as mammography, ultrasound, or MRI, or through self-examination or clinical examination. Treatment options for breast neoplasms depend on several factors, including the type and stage of the tumor, the patient's age and overall health, and personal preferences. Treatment may include surgery, radiation therapy, chemotherapy, hormone therapy, or targeted therapy.

I'm sorry for any confusion, but I was unable to find a medical definition for "Flurogestone Acetate." It is possible that there may be a spelling error or it could be a medication that is not widely recognized in the medical field. If you have more information about this term, such as its alternate names or the context in which it's used, I might be able to provide a more accurate response.

Fluorogestone acetate is a synthetic progestogen, which is a type of hormone that is similar to the natural progesterone produced by the body. It has been used in some formulations for hormonal contraception and hormone replacement therapy. However, it's important to note that specific medications and their uses may vary depending on the country and region, so I cannot provide a definitive medical definition without more context.

If you have any concerns about your medication or its effects, please consult with a healthcare professional for accurate information tailored to your situation.

17-α-Hydroxyprogesterone is a naturally occurring hormone produced by the adrenal glands and, in smaller amounts, by the ovaries and testes. It is an intermediate in the biosynthesis of steroid hormones, including cortisol, aldosterone, and sex hormones such as testosterone and estrogen.

In a medical context, 17-α-Hydroxyprogesterone may also refer to a synthetic form of this hormone that is used in the treatment of certain medical conditions. For example, a medication called 17-alpha-hydroxyprogesterone caproate (17-OHP) is used to reduce the risk of preterm birth in women who have previously given birth prematurely. It works by suppressing uterine contractions and promoting fetal lung maturity.

It's important to note that 17-alpha-Hydroxyprogesterone should only be used under the supervision of a healthcare provider, as it can have side effects and may interact with other medications.

Contraceptive agents for males are substances or methods that are used to prevent pregnancy by reducing the likelihood of fertilization. These can include:

1. Barrier methods: Condoms, diaphragms, and spermicides create a physical barrier that prevents sperm from reaching the egg.
2. Hormonal methods: Testosterone and progestin hormone therapies can decrease sperm production and reduce fertility.
3. Intrauterine devices (IUDs) for men: These are still in the experimental stage, but they involve placing a device in the male reproductive tract to prevent sperm from reaching the female reproductive system.
4. Withdrawal method: This involves the man withdrawing his penis from the vagina before ejaculation, although this is not a highly reliable form of contraception.
5. Fertility awareness methods: These involve tracking the woman's menstrual cycle and avoiding sexual intercourse during her fertile period.
6. Sterilization: Vasectomy is a surgical procedure that blocks or cuts the vas deferens, preventing sperm from leaving the body. It is a permanent form of contraception for men.

It's important to note that no contraceptive method is 100% effective, and individuals should consult with their healthcare provider to determine which option is best for them based on their personal needs, lifestyle, and medical history.

I'm sorry for any confusion, but "Pregnanediones" is not a recognized term in medical terminology or pharmacology. It seems that the term may be a combination of "pregnan" (a root word related to steroid hormones produced by the ovaries and testes) and "dione" (a suffix used in chemistry to denote a ketone with two carbonyl groups). However, without a clear context or a specific chemical structure, it's not possible to provide an accurate definition or description.

If you have any more information about the term or if you meant something different, please let me know and I will do my best to help you.

I apologize for any confusion, but "Algestone" is not a recognized medical term or drug name in common usage. It's possible that there might be some misunderstanding or miscommunication regarding the term. If you have more context or information about where this term came from, I'd be happy to help you try to clarify it.

However, if you are referring to "Algestone acetonide," it is a synthetic corticosteroid used in some medical creams and gels for its anti-inflammatory and antipruritic (anti-itching) properties. It's commonly used to treat skin conditions such as eczema, dermatitis, and psoriasis.

If you have any further questions or need more information about a specific medical topic, please don't hesitate to ask!

Estrogen receptors (ERs) are a type of nuclear receptor protein that are expressed in various tissues and cells throughout the body. They play a critical role in the regulation of gene expression and cellular responses to the hormone estrogen. There are two main subtypes of ERs, ERα and ERβ, which have distinct molecular structures, expression patterns, and functions.

ERs function as transcription factors that bind to specific DNA sequences called estrogen response elements (EREs) in the promoter regions of target genes. When estrogen binds to the ER, it causes a conformational change in the receptor that allows it to recruit co-activator proteins and initiate transcription of the target gene. This process can lead to a variety of cellular responses, including changes in cell growth, differentiation, and metabolism.

Estrogen receptors are involved in a wide range of physiological processes, including the development and maintenance of female reproductive tissues, bone homeostasis, cardiovascular function, and cognitive function. They have also been implicated in various pathological conditions, such as breast cancer, endometrial cancer, and osteoporosis. As a result, ERs are an important target for therapeutic interventions in these diseases.

Mestranol is a synthetic form of estrogen, which is a female sex hormone used in oral contraceptives and hormone replacement therapy. It works by preventing the release of an egg from the ovary (ovulation) and altering the cervical mucus and the lining of the uterus to make it more difficult for sperm to reach the egg or for an already established pregnancy to be implanted.

Mestranol is typically combined with a progestin in birth control pills, such as those known as the "combined oral contraceptives." It's important to note that mestranol has largely been replaced by ethinyl estradiol, which is a more commonly used form of synthetic estrogen in hormonal medications.

As with any medication, there are potential risks and side effects associated with the use of mestranol, including an increased risk of blood clots, stroke, and certain types of cancer. It's essential to consult with a healthcare provider before starting or changing any hormonal medication.

Hormone antagonists are substances or drugs that block the action of hormones by binding to their receptors without activating them, thereby preventing the hormones from exerting their effects. They can be classified into two types: receptor antagonists and enzyme inhibitors. Receptor antagonists bind directly to hormone receptors and prevent the hormone from binding, while enzyme inhibitors block the production or breakdown of hormones by inhibiting specific enzymes involved in their metabolism. Hormone antagonists are used in the treatment of various medical conditions, such as cancer, hormonal disorders, and cardiovascular diseases.

Pregnenolone is defined as a neurosteroid, which is a steroid hormone that is produced in the nervous system. It is synthesized from cholesterol and is the precursor to other steroid hormones, including progesterone, cortisol, and the sex hormones (estrogens and androgens). Pregnenolone has been shown to have a number of important functions in the body, including modulation of neurotransmitter systems, regulation of ion channels, and protection of nerve cells from damage. It is thought to play a role in various physiological processes, such as memory, learning, and mood regulation. However, more research is needed to fully understand its mechanisms of action and therapeutic potential.

Estradiol dehydrogenases are a group of enzymes that are involved in the metabolism of estradiols, which are steroid hormones that play important roles in the development and maintenance of female reproductive system and secondary sexual characteristics. These enzymes catalyze the oxidation or reduction reactions of estradiols, converting them to other forms of steroid hormones.

There are two main types of estradiol dehydrogenases: 1) 3-alpha-hydroxysteroid dehydrogenase (3-alpha HSD), which catalyzes the conversion of estradi-17-beta to estrone, and 2) 17-beta-hydroxysteroid dehydrogenase (17-beta HSD), which catalyzes the reverse reaction, converting estrone back to estradiol.

These enzymes are widely distributed in various tissues, including the ovaries, placenta, liver, and adipose tissue, and play important roles in regulating the levels of estradiols in the body. Abnormalities in the activity of these enzymes have been associated with several medical conditions, such as hormone-dependent cancers, polycystic ovary syndrome, and hirsutism.

A hysterectomy is a surgical procedure that involves the removal of the uterus (womb). Depending on the specific medical condition and necessity, a hysterectomy may also include the removal of the ovaries, fallopian tubes, and surrounding tissues. There are different types of hysterectomies, including:

1. Total hysterectomy: The uterus and cervix are removed.
2. Supracervical (or subtotal) hysterectomy: Only the upper part of the uterus is removed, leaving the cervix intact.
3. Radical hysterectomy: This procedure involves removing the uterus, cervix, surrounding tissues, and the upper part of the vagina. It is typically performed in cases of cervical cancer.
4. Oophorectomy: The removal of one or both ovaries can be performed along with a hysterectomy depending on the patient's medical condition and age.
5. Salpingectomy: The removal of one or both fallopian tubes can also be performed along with a hysterectomy if needed.

The reasons for performing a hysterectomy may include but are not limited to: uterine fibroids, heavy menstrual bleeding, endometriosis, adenomyosis, pelvic prolapse, cervical or uterine cancer, and chronic pelvic pain. The choice of the type of hysterectomy depends on the patient's medical condition, age, and personal preferences.

Estrus is a term used in veterinary medicine to describe the physiological and behavioral state of female mammals that are ready to mate and conceive. It refers to the period of time when the female's reproductive system is most receptive to fertilization.

During estrus, the female's ovaries release one or more mature eggs (ovulation) into the fallopian tubes, where they can be fertilized by sperm from a male. This phase of the estrous cycle is often accompanied by changes in behavior and physical appearance, such as increased vocalization, restlessness, and swelling of the genital area.

The duration and frequency of estrus vary widely among different species of mammals. In some animals, such as dogs and cats, estrus occurs regularly at intervals of several weeks or months, while in others, such as cows and mares, it may only occur once or twice a year.

It's important to note that the term "estrus" is not used to describe human reproductive physiology. In humans, the equivalent phase of the menstrual cycle is called ovulation.

Pregnenolone is defined as a steroid hormone produced in the body from cholesterol. It's often referred to as the "mother hormone" since many other hormones, including cortisol, aldosterone, progesterone, testosterone, and estrogen, are synthesized from it.

Pregnenolone is primarily produced in the adrenal glands but can also be produced in smaller amounts in the brain, skin, and sex organs (ovaries and testes). It plays a crucial role in various physiological processes such as maintaining membrane fluidity, acting as an antioxidant, and contributing to cognitive function.

However, it's important to note that while pregnenolone is a hormone, over-the-counter supplements containing this compound are not approved by the FDA for any medical use or condition. As always, consult with a healthcare provider before starting any new supplement regimen.

Contraceptive agents are substances or medications that are used to prevent pregnancy by interfering with the normal process of conception and fertilization or the development and implantation of the fertilized egg. They can be divided into two main categories: hormonal and non-hormonal methods.

Hormonal contraceptive agents include combined oral contraceptives (COCs), progestin-only pills, patches, rings, injections, and implants. These methods work by releasing synthetic hormones that mimic the natural hormones estrogen and progesterone in a woman's body. By doing so, they prevent ovulation, thicken cervical mucus to make it harder for sperm to reach the egg, and thin the lining of the uterus to make it less likely for a fertilized egg to implant.

Non-hormonal contraceptive agents include barrier methods such as condoms, diaphragms, cervical caps, and sponges, which prevent sperm from reaching the egg by creating a physical barrier. Other non-hormonal methods include intrauterine devices (IUDs), which are inserted into the uterus to prevent pregnancy, and fertility awareness-based methods, which involve tracking ovulation and avoiding intercourse during fertile periods.

Emergency contraceptive agents, such as Plan B or ella, can also be used to prevent pregnancy after unprotected sex or contraceptive failure. These methods work by preventing or delaying ovulation, preventing fertilization, or preventing implantation of a fertilized egg.

It's important to note that while contraceptive agents are effective at preventing pregnancy, they do not protect against sexually transmitted infections (STIs). Using condoms in addition to other forms of contraception can help reduce the risk of STIs.

Uterine neoplasms refer to abnormal growths in the uterus, which can be benign (non-cancerous) or malignant (cancerous). These growths can originate from different types of cells within the uterus, leading to various types of uterine neoplasms. The two main categories of uterine neoplasms are endometrial neoplasms and uterine sarcomas.

Endometrial neoplasms develop from the endometrium, which is the inner lining of the uterus. Most endometrial neoplasms are classified as endometrioid adenocarcinomas, arising from glandular cells in the endometrium. Other types include serous carcinoma, clear cell carcinoma, and mucinous carcinoma.

Uterine sarcomas, on the other hand, are less common and originate from the connective tissue (stroma) or muscle (myometrium) of the uterus. Uterine sarcomas can be further divided into several subtypes, such as leiomyosarcoma, endometrial stromal sarcoma, and undifferentiated uterine sarcoma.

Uterine neoplasms can cause various symptoms, including abnormal vaginal bleeding or discharge, pelvic pain, and difficulty urinating or having bowel movements. The diagnosis typically involves a combination of imaging tests (such as ultrasound, CT, or MRI scans) and tissue biopsies to determine the type and extent of the neoplasm. Treatment options depend on the type, stage, and patient's overall health but may include surgery, radiation therapy, chemotherapy, or hormone therapy.

Steroids, also known as corticosteroids, are a type of hormone that the adrenal gland produces in your body. They have many functions, such as controlling the balance of salt and water in your body and helping to reduce inflammation. Steroids can also be synthetically produced and used as medications to treat a variety of conditions, including allergies, asthma, skin conditions, and autoimmune disorders.

Steroid medications are available in various forms, such as oral pills, injections, creams, and inhalers. They work by mimicking the effects of natural hormones produced by your body, reducing inflammation and suppressing the immune system's response to prevent or reduce symptoms. However, long-term use of steroids can have significant side effects, including weight gain, high blood pressure, osteoporosis, and increased risk of infections.

It is important to note that anabolic steroids are a different class of drugs that are sometimes abused for their muscle-building properties. These steroids are synthetic versions of the male hormone testosterone and can have serious health consequences when taken in large doses or without medical supervision.

The uterus, also known as the womb, is a hollow, muscular organ located in the female pelvic cavity, between the bladder and the rectum. It has a thick, middle layer called the myometrium, which is composed of smooth muscle tissue, and an inner lining called the endometrium, which provides a nurturing environment for the fertilized egg to develop into a fetus during pregnancy.

The uterus is where the baby grows and develops until it is ready for birth through the cervix, which is the lower, narrow part of the uterus that opens into the vagina. The uterus plays a critical role in the menstrual cycle as well, by shedding its lining each month if pregnancy does not occur.

Pregnanediol is a steroid hormone that is produced as a metabolite of progesterone. It is primarily used as a biomarker to measure the exposure to progesterone, particularly in cases where progesterone levels need to be monitored, such as during pregnancy or in certain medical conditions. Pregnanediol can be measured in urine, blood, or other bodily fluids and is often used in clinical and research settings to assess hormonal status. It is important to note that pregnanediol itself does not have any known physiological effects on the body, but rather serves as an indicator of progesterone levels.

Ovariectomy is a surgical procedure in which one or both ovaries are removed. It is also known as "ovary removal" or "oophorectomy." This procedure is often performed as a treatment for various medical conditions, including ovarian cancer, endometriosis, uterine fibroids, and pelvic pain. Ovariectomy can also be part of a larger surgical procedure called an hysterectomy, in which the uterus is also removed.

In some cases, an ovariectomy may be performed as a preventative measure for individuals at high risk of developing ovarian cancer. This is known as a prophylactic ovariectomy. After an ovariectomy, a person will no longer have menstrual periods and will be unable to become pregnant naturally. Hormone replacement therapy may be recommended in some cases to help manage symptoms associated with the loss of hormones produced by the ovaries.

20-α-Hydroxysteroid Dehydrogenase (20-α-HSD) is an enzyme that catalyzes the conversion of steroids, specifically the oxidation of 20α-hydroxysteroids to 20-keto steroids. This enzyme plays a crucial role in the metabolism and regulation of steroid hormones, such as corticosteroids and progestogens.

In the adrenal gland, 20-α-HSD is involved in the biosynthesis and interconversion of various corticosteroids, including cortisol, cortisone, and aldosterone. By catalyzing the conversion of cortisol to cortisone or vice versa, this enzyme helps maintain a balance between active and inactive forms of these hormones, which is essential for proper physiological functioning.

In the reproductive system, 20-α-HSD is involved in the metabolism of progestogens, such as progesterone and its derivatives. This enzyme can convert active forms of progestogens into their inactive counterparts, thereby regulating their levels and activity within the body.

Dysregulation or mutations in 20-α-HSD have been implicated in several medical conditions, including adrenal insufficiency, congenital adrenal hyperplasia, and certain reproductive disorders.

Pregnanes are a class of steroid hormones and steroids that contain a pregnane nucleus, which is a steroid core with a carbon skeleton consisting of 21 carbons. This structure includes four fused rings, labeled A through D, and is derived from cholesterol.

Pregnanes are important precursors for the synthesis of various steroid hormones in the body, including progesterone, which plays a crucial role in maintaining pregnancy and regulating the menstrual cycle. Other examples of pregnanes include cortisol, a stress hormone produced by the adrenal gland, and aldosterone, a hormone that helps regulate electrolyte balance and blood pressure.

It's worth noting that pregnanes can also refer to synthetic compounds that contain this steroid nucleus and are used in various medical and research contexts.

Ovulation is the medical term for the release of a mature egg from an ovary during a woman's menstrual cycle. The released egg travels through the fallopian tube where it may be fertilized by sperm if sexual intercourse has occurred recently. If the egg is not fertilized, it will break down and leave the body along with the uterine lining during menstruation. Ovulation typically occurs around day 14 of a 28-day menstrual cycle, but the timing can vary widely from woman to woman and even from cycle to cycle in the same woman.

During ovulation, there are several physical changes that may occur in a woman's body, such as an increase in basal body temperature, changes in cervical mucus, and mild cramping or discomfort on one side of the lower abdomen (known as mittelschmerz). These symptoms can be used to help predict ovulation and improve the chances of conception.

It's worth noting that some medical conditions, such as polycystic ovary syndrome (PCOS) or premature ovarian failure, may affect ovulation and make it difficult for a woman to become pregnant. In these cases, medical intervention may be necessary to help promote ovulation and increase the chances of conception.

Estradiol antagonists, also known as antiestrogens, are a class of drugs that block the effects of estradiol, a female sex hormone, by binding to estrogen receptors without activating them. This results in the inhibition of estrogen-mediated activities in the body.

These drugs are often used in the treatment of hormone-sensitive cancers, such as breast cancer, where estrogen can promote the growth of cancer cells. By blocking the effects of estrogen, estradiol antagonists can help to slow or stop the growth of these cancer cells and reduce the risk of cancer recurrence.

Examples of estradiol antagonists include tamoxifen, raloxifene, and fulvestrant. While these drugs are generally well-tolerated, they can cause side effects such as hot flashes, mood changes, and vaginal dryness. In some cases, they may also increase the risk of blood clots and endometrial cancer.

Trenbolone Acetate is an esterified form of the synthetic steroid hormone Trenbolone. It is a potent anabolic and androgenic steroid, which is used in veterinary medicine for promoting muscle growth and appetite stimulation in cattle. In human medicine, it is not approved for use but is sometimes misused for its anabolic effects, such as increasing muscle mass, strength, and reducing body fat. It is important to note that the use of Trenbolone Acetate in humans is considered off-label and can lead to serious health consequences, including liver toxicity, cardiovascular issues, and hormonal imbalances.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

Estradiol congeners refer to chemical compounds that are structurally similar to estradiol, which is the most potent and prevalent form of estrogen in humans. Estradiol congeners can be naturally occurring or synthetic and may have similar or different biological activities compared to estradiol.

These compounds can be found in various sources, including plants, animals, and industrial products. Some estradiol congeners are used in pharmaceuticals as hormone replacement therapies, while others are considered environmental pollutants and may have endocrine-disrupting effects on wildlife and humans.

Examples of estradiol congeners include:

1. Estrone (E1): a weak estrogen that is produced in the body from estradiol and is also found in some plants.
2. Estriol (E3): a weaker estrogen that is produced in large quantities during pregnancy.
3. Diethylstilbestrol (DES): a synthetic estrogen that was prescribed to pregnant women from the 1940s to the 1970s to prevent miscarriage, but was later found to have serious health effects on their offspring.
4. Zeranol: a synthetic non-steroidal estrogen used as a growth promoter in livestock.
5. Bisphenol A (BPA): a chemical used in the production of plastics and epoxy resins, which has been shown to have weak estrogenic activity and may disrupt the endocrine system.

The corpus luteum is a temporary endocrine structure that forms in the ovary after an oocyte (egg) has been released from a follicle during ovulation. It's formed by the remaining cells of the ruptured follicle, which transform into large, hormone-secreting cells.

The primary function of the corpus luteum is to produce progesterone and, to a lesser extent, estrogen during the menstrual cycle or pregnancy. Progesterone plays a crucial role in preparing the uterus for potential implantation of a fertilized egg and maintaining the early stages of pregnancy. If pregnancy does not occur, the corpus luteum will typically degenerate and stop producing hormones after approximately 10-14 days, leading to menstruation.

However, if pregnancy occurs, the developing embryo starts to produce human chorionic gonadotropin (hCG), which signals the corpus luteum to continue secreting progesterone and estrogen until the placenta takes over hormonal production, usually around the end of the first trimester.

An ovary is a part of the female reproductive system in which ova or eggs are produced through the process of oogenesis. They are a pair of solid, almond-shaped structures located one on each side of the uterus within the pelvic cavity. Each ovary measures about 3 to 5 centimeters in length and weighs around 14 grams.

The ovaries have two main functions: endocrine (hormonal) function and reproductive function. They produce and release eggs (ovulation) responsible for potential fertilization and development of an embryo/fetus during pregnancy. Additionally, they are essential in the production of female sex hormones, primarily estrogen and progesterone, which regulate menstrual cycles, sexual development, and reproduction.

During each menstrual cycle, a mature egg is released from one of the ovaries into the fallopian tube, where it may be fertilized by sperm. If not fertilized, the egg, along with the uterine lining, will be shed, leading to menstruation.

Danazol is a synthetic, orally active androgenic steroid with antigonadotropic properties. It is used primarily in the treatment of endometriosis, fibrocystic breast disease, and hereditary angioedema. Danazol works by suppressing the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the pituitary gland, which in turn inhibits the growth of ovarian tissue and reduces the production of estrogen and progesterone. This leads to a decrease in the symptoms associated with endometriosis and fibrocystic breast disease. In the case of hereditary angioedema, danazol helps prevent attacks by increasing the levels of a protein called C1 esterase inhibitor, which is necessary for regulating the immune system and preventing inflammation.

The common side effects of danazol include weight gain, acne, oily skin, increased hair growth, changes in menstrual cycle, decreased breast size, deepening of the voice, and emotional lability. Rare but serious side effects may include liver damage, blood clots, and adrenal gland problems. Danazol is contraindicated in pregnancy due to its potential virilizing effects on the fetus. It should be used with caution in individuals with a history of liver disease, heart disease, or seizure disorders.

The medical definition of danazol can be summarized as follows:

Danazol (dan-a-zole)

A synthetic androgenic steroid with antigonadotropic properties, used primarily in the treatment of endometriosis, fibrocystic breast disease, and hereditary angioedema. Danazol suppresses the release of FSH and LH from the pituitary gland, inhibiting ovarian tissue growth and reducing estrogen and progesterone production. In hereditary angioedema, danazol increases C1 esterase inhibitor levels to prevent attacks. Common side effects include weight gain, acne, increased hair growth, menstrual changes, decreased breast size, deepened voice, and emotional lability. Rare but serious side effects may involve liver damage, blood clots, or adrenal gland problems. Danazol is contraindicated in pregnancy due to potential virilizing effects on the fetus and should be used with caution in individuals with a history of liver disease, heart disease, or seizure disorders.

Menstruation is the regular, cyclical shedding of the uterine lining (endometrium) in women and female individuals of reproductive age, accompanied by the discharge of blood and other materials from the vagina. It typically occurs every 21 to 35 days and lasts for approximately 2-7 days. This process is a part of the menstrual cycle, which is under the control of hormonal fluctuations involving follicle-stimulating hormone (FSH), luteinizing hormone (LH), estrogen, and progesterone.

The menstrual cycle can be divided into three main phases:

1. Menstruation phase: The beginning of the cycle is marked by the start of menstrual bleeding, which signals the breakdown and shedding of the endometrium due to the absence of pregnancy and low levels of estrogen and progesterone. This phase typically lasts for 2-7 days.

2. Proliferative phase: After menstruation, under the influence of rising estrogen levels, the endometrium starts to thicken and regenerate. The uterine lining becomes rich in blood vessels and glands, preparing for a potential pregnancy. This phase lasts from day 5 until around day 14 of an average 28-day cycle.

3. Secretory phase: Following ovulation (release of an egg from the ovaries), which usually occurs around day 14, increased levels of progesterone cause further thickening and maturation of the endometrium. The glands in the lining produce nutrients to support a fertilized egg. If pregnancy does not occur, both estrogen and progesterone levels will drop, leading to menstruation and the start of a new cycle.

Understanding menstruation is essential for monitoring reproductive health, identifying potential issues such as irregular periods or menstrual disorders, and planning family planning strategies.

Spermatogenesis-blocking agents are a class of medications or substances that inhibit or block the process of spermatogenesis, which is the production of sperm in the testicles. These agents can work at various stages of spermatogenesis, including reducing the number of spermatozoa (sperm cells) or preventing the formation of mature sperm.

Examples of spermatogenesis-blocking agents include:

1. Hormonal agents: Certain hormones or hormone-like substances can interfere with the production of sperm. For example, analogs of gonadotropin-releasing hormone (GnRH) and antiandrogens can suppress the release of testosterone and other hormones necessary for spermatogenesis.
2. Alkylating agents: These are chemotherapy drugs that can damage DNA and prevent the division and multiplication of cells, including sperm cells. Examples include cyclophosphamide and busulfan.
3. Other chemicals: Certain industrial chemicals, such as ethylene glycol ethers and dibromochloropropane (DBCP), have been shown to have spermatogenesis-blocking properties.
4. Radiation therapy: High doses of radiation can also damage the testicles and inhibit sperm production.

It's important to note that spermatogenesis-blocking agents are often used for medical purposes, such as treating cancer or preventing pregnancy, but they can have significant side effects and should only be used under the guidance of a healthcare professional.

Dihydrotestosterone (DHT) is a sex hormone and androgen that plays a critical role in the development and maintenance of male characteristics, such as facial hair, deep voice, and muscle mass. It is synthesized from testosterone through the action of the enzyme 5-alpha reductase. DHT is essential for the normal development of the male genitalia during fetal development and for the maturation of the sexual organs at puberty.

In addition to its role in sexual development, DHT also contributes to the growth of hair follicles, the health of the prostate gland, and the maintenance of bone density. However, an excess of DHT has been linked to certain medical conditions, such as benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern baldness).

DHT exerts its effects by binding to androgen receptors in various tissues throughout the body. Once bound, DHT triggers a series of cellular responses that regulate gene expression and influence the growth and differentiation of cells. In some cases, these responses can lead to unwanted side effects, such as hair loss or prostate enlargement.

Medications that block the action of 5-alpha reductase, such as finasteride and dutasteride, are sometimes used to treat conditions associated with excess DHT production. These drugs work by reducing the amount of DHT available to bind to androgen receptors, thereby alleviating symptoms and slowing disease progression.

In summary, dihydrotestosterone is a potent sex hormone that plays a critical role in male sexual development and function. While it is essential for normal growth and development, an excess of DHT has been linked to certain medical conditions, such as BPH and androgenetic alopecia. Medications that block the action of 5-alpha reductase are sometimes used to treat these conditions by reducing the amount of DHT available to bind to androgen receptors.

Dimethisterone is a synthetic progestin, which is a type of female sex hormone. It is not commonly used in clinical medicine today, but it has been used in the past to treat various conditions such as endometriosis, breast cancer, and menstrual disorders. Progestins like dimethisterone work by mimicking the actions of natural progesterone in the body, which helps to regulate the menstrual cycle and support pregnancy.

Like other progestins, dimethisterone can cause a variety of side effects, including nausea, vomiting, bloating, breast tenderness, mood changes, and irregular menstrual bleeding. It may also increase the risk of certain serious conditions such as blood clots, stroke, and breast cancer with long-term use.

It is important to note that the use of dimethisterone and other progestins should be monitored carefully by a healthcare provider to ensure safe and effective treatment.

Androgens are a class of hormones that are primarily responsible for the development and maintenance of male sexual characteristics and reproductive function. Testosterone is the most well-known androgen, but other androgens include dehydroepiandrosterone (DHEA), androstenedione, and dihydrotestosterone (DHT).

Androgens are produced primarily by the testes in men and the ovaries in women, although small amounts are also produced by the adrenal glands in both sexes. They play a critical role in the development of male secondary sexual characteristics during puberty, such as the growth of facial hair, deepening of the voice, and increased muscle mass.

In addition to their role in sexual development and function, androgens also have important effects on bone density, mood, and cognitive function. Abnormal levels of androgens can contribute to a variety of medical conditions, including infertility, erectile dysfunction, acne, hirsutism (excessive hair growth), and prostate cancer.

Oral contraceptives, sequential, are a type of birth control medication that involves taking two different hormonal preparations in a specific sequence to mimic the natural menstrual cycle. The first hormone preparation contains estrogen and is taken for 16-21 days, followed by a second hormone preparation containing both estrogen and progestin for 7 days. This regimen causes the lining of the uterus to thin, making it less likely for a fertilized egg to implant, and also thickens cervical mucus, which can prevent sperm from reaching the egg. Sequential oral contraceptives are not commonly used in the United States due to their higher risk of side effects compared to other forms of oral contraceptives.

Menstruation-inducing agents, also known as menstrual induction agents or abortifacients, are medications or substances that stimulate or induce menstruation and can potentially lead to the termination of an early pregnancy. These agents work by causing the uterus to contract and expel its lining (endometrium), which is shed during menstruation.

Common menstruation-inducing agents include:

1. Hormonal medications: Combination oral contraceptives, containing both estrogen and progestin, can be used to induce menstruation by causing the uterus to shed its lining after a planned break from taking the medication. This is often used in birth control methods like the "birth control pill pack."
2. Prostaglandins: These are naturally occurring hormone-like substances that can cause the uterus to contract. Synthetic prostaglandin analogs, such as misoprostol (Cytotec), can be used to induce menstruation or early pregnancy termination.
3. Mifepristone: This is a synthetic steroid hormone that blocks progesterone receptors in the body. When used in combination with prostaglandins, it can cause the uterus to contract and expel its lining, leading to an abortion or inducing menstruation.

It's important to note that using menstruation-inducing agents without medical supervision or for purposes other than their intended use may pose health risks and should be avoided. Always consult a healthcare professional before using any medication for this purpose.

Metrorrhagia is defined as uterine bleeding that occurs at irregular intervals, particularly between expected menstrual periods. It can also be described as abnormal vaginal bleeding that is not related to the regular menstrual cycle. The amount of bleeding can vary from light spotting to heavy flow.

Metrorrhagia is different from menorrhagia, which refers to excessive or prolonged menstrual bleeding during the menstrual period. Metrorrhagia can be caused by various factors, including hormonal imbalances, uterine fibroids, polyps, endometrial hyperplasia, infection, pregnancy complications, and certain medications or medical conditions.

It is essential to consult a healthcare provider if you experience any abnormal vaginal bleeding to determine the underlying cause and receive appropriate treatment.

A drug combination refers to the use of two or more drugs in combination for the treatment of a single medical condition or disease. The rationale behind using drug combinations is to achieve a therapeutic effect that is superior to that obtained with any single agent alone, through various mechanisms such as:

* Complementary modes of action: When different drugs target different aspects of the disease process, their combined effects may be greater than either drug used alone.
* Synergistic interactions: In some cases, the combination of two or more drugs can result in a greater-than-additive effect, where the total response is greater than the sum of the individual responses to each drug.
* Antagonism of adverse effects: Sometimes, the use of one drug can mitigate the side effects of another, allowing for higher doses or longer durations of therapy.

Examples of drug combinations include:

* Highly active antiretroviral therapy (HAART) for HIV infection, which typically involves a combination of three or more antiretroviral drugs to suppress viral replication and prevent the development of drug resistance.
* Chemotherapy regimens for cancer treatment, where combinations of cytotoxic agents are used to target different stages of the cell cycle and increase the likelihood of tumor cell death.
* Fixed-dose combination products, such as those used in the treatment of hypertension or type 2 diabetes, which combine two or more active ingredients into a single formulation for ease of administration and improved adherence to therapy.

However, it's important to note that drug combinations can also increase the risk of adverse effects, drug-drug interactions, and medication errors. Therefore, careful consideration should be given to the selection of appropriate drugs, dosing regimens, and monitoring parameters when using drug combinations in clinical practice.

"Gonanes" is not a recognized medical term. However, in the field of chemistry and pharmacology, gonanes refer to a class of steroidal compounds that have a chemical structure similar to testosterone, which is the primary male sex hormone. These compounds are often used as the basis for developing drugs that can affect the reproductive system or other systems in the body that are influenced by testosterone and its derivatives.

It's important to note that while gonanes may have implications for medical research and drug development, they do not have a specific medical definition in the same way that terms like "myocardial infarction" or "diabetes mellitus" do.

3-Hydroxysteroid dehydrogenases (3-HSDs) are a group of enzymes that play a crucial role in steroid hormone biosynthesis. These enzymes catalyze the conversion of 3-beta-hydroxy steroids to 3-keto steroids, which is an essential step in the production of various steroid hormones, including progesterone, cortisol, aldosterone, and sex hormones such as testosterone and estradiol.

There are several isoforms of 3-HSDs that are expressed in different tissues and have distinct substrate specificities. For instance, 3-HSD type I is primarily found in the ovary and adrenal gland, where it catalyzes the conversion of pregnenolone to progesterone and 17-hydroxyprogesterone to 17-hydroxycortisol. On the other hand, 3-HSD type II is mainly expressed in the testes, adrenal gland, and placenta, where it catalyzes the conversion of dehydroepiandrosterone (DHEA) to androstenedione and androstenedione to testosterone.

Defects in 3-HSDs can lead to various genetic disorders that affect steroid hormone production and metabolism, resulting in a range of clinical manifestations such as adrenal insufficiency, ambiguous genitalia, and sexual development disorders.

Pregnancy maintenance refers to the ongoing process and care required to support and sustain a healthy pregnancy until childbirth. This includes regular prenatal check-ups to monitor the health of both the mother and the developing fetus, proper nutrition, regular exercise, and avoiding harmful behaviors such as smoking or consuming alcohol. In some cases, pregnancy maintenance may also include medical interventions such as hormone treatments or bed rest. The goal of pregnancy maintenance is to ensure the best possible outcome for both the mother and the baby.

... so orally active progestins were tried beginning with ethisterone, followed by other progestins as they became available: ... Genital ambiguity due to progestin exposure in pregnancy is thus mostly a topic of historical concern. The first drugs reported ... Loose, Davis S.; Stancel, George M. (2006). "Estrogens and Progestins". In Brunton, Laurence L.; Lazo, John S.; Parker, Keith L ... Wilkins L (March 5, 1960). "Masculinization of female fetus due to use of orally given progestins". JAMA. 172 (10): 1028-32. ...
The progestin and adipoQ receptor (PAQR) family is a group of receptors related to but distinct from the G protein-coupled ...
Henzl MR, Edwards JA (10 November 1999). "Pharmacology of Progestins: 17α-Hydroxyprogesterone Derivatives and Progestins of the ... Like other potent progestins, gestonorone caproate possesses potent antigonadotropic activity and is capable of markedly ... Gestonorone caproate is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the ... ISBN 978-3-88763-075-1. "List of Progestins". "Micromedex Products: Please Login". Sweetman SC, ed. (2009). "Sex hormones and ...
Thorneycroft IH (November 2002). "Evolution of progestins. Focus on the novel progestin drospirenone". J Reprod Med. 47 (11 ... whereas this may occur less or not at all with weakly androgenic progestins like desogestrel and antiandrogenic progestins like ... in contrast to androgenic progestins like levonorgestrel but similarly to other antiandrogenic progestins like cyproterone ... Drospirenone is a progestin and antiandrogen medication which is used in birth control pills to prevent pregnancy and in ...
Loose DS, Stancel GM (2006). "Estrogens and Progestins". In Brunton LL, Lazo JS, Parker KL (eds.). Goodman & Gilman's The ... Committee on Anti-progestins: Assessing the Science; Division of Health Promotion and Disease Prevention; Institute of Medicine ... delays ovulation by three to four days and is as effective an emergency contraceptive as a single 1.5-mg dose of the progestin ...
... , sold under the brand names Covinan and Delvosteron, is a progestin medication which is used in veterinary ... 882-. ISBN 978-3-88763-075-1. "List of Progestins". Mundt, S. (22 April 1981). "Indications for proligestone (Delvosteron) in ...
"List of Progestins". Drugs.com. Court EA, Watson AD, Church DB, Emslie DR (August 1998). "Effects of delmadinone acetate on ... Delmadinone acetate (DMA), sold under the brand name Tardak among others, is a progestin and antiandrogen which is used in ... "Structure-activity relationships of synthetic progestins in a yeast-based in vitro androgen bioassay". The Journal of Steroid ...
... are esters of progestins (synthetic progestogens) and are non-bioidentical. In addition, whereas all androgen and estrogen ... Progestin No. 1) Edogestrone (edogesterone; PH-218) Hydromadinone acetate (chloroacetoxyprogesterone; CAP; NSC-33170) ... ISBN 978-3-88763-075-1. "List of Progestins". http://www.micromedexsolutions.com Sweetman, Sean C., ed. (2009). "Sex hormones ...
ISBN 978-0-7216-0376-6. Loose DS, Stancel GM (2006). "Estrogens and Progestins". In Brunton LL, Lazo JS, Parker KL (eds.). ...
... is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological ... Chan DW, Slaunwhite WR (May 1977). "The binding of a synthetic progestin, R5020 to transcortin and serum albumin". The Journal ... Promegestone, sold under the brand name Surgestone, is a progestin medication which is used in menopausal hormone therapy and ... Winneker RC, Bitran D, Zhang Z (November 2003). "The preclinical biology of a new potent and selective progestin: trimegestone ...
Henzl MR, Edwards JA (10 November 1999). "Pharmacology of Progestins: 17α-Hydroxyprogesterone Derivatives and Progestins of the ... Along with other progestins, MPA was developed to allow for oral progestogen therapy, as progesterone (the progestogen hormone ... A 2018 meta-analysis reported that MPA was associated with a 2.8-fold higher risk of VTE than other progestins. It is possible ... There have been concerns about a possible risk of depression and mood changes with progestins like MPA, and this has led to ...
The progestins in all COCs provide most of the contraceptive effect by suppressing ovulation and thickening cervical mucus, ... Plan B one step was the first levonorgestrel progestin-only EC approved by the FDA in 1999. Currently, there are many different ... "Progestin-only Contraceptives". Hall Health Primary Care Center. University of Wisconsin-Seattle. 2007-02-11. Archived from the ... The first progestogen-only contraceptive was introduced in 1969: Depo-Provera, a high-dose progestin injection. Over the next ...
... like other progestins available thus far, nor‐progestins should not be administered alone for male contraception because their ... Progestin-only emergency contraceptive pills. Early treatment with ECPs containing only the progestin levonorgestrel has been ... the biologically active form of this progestin). The progestins of this class are known to be potent suppressors of ... It is a progestin and has effects similar to those of the hormone progesterone. It works primarily by preventing ovulation and ...
Henzl MR, Edwards JA (10 November 1999). "Pharmacology of Progestins: 17α-Hydroxyprogesterone Derivatives and Progestins of the ... Table 1 Publications on ovulation inhibition doses of progestins: Progestin: Progesterone. Reference: Pincus (1956). Method: ... Certain progestins have been found to stimulate the proliferation of MCF-7 breast cancer cells in vitro, an action that is ... As such, progesterone differs from some but not all progestins in the activity mediating this PGRMC1-dependent effect. It is ...
Based on results in the animal bioassays, CPA has also been said to be the most potent progestin known, with 1,000 times the ... Zitzmann M, Rohayem J, Raidt J, Kliesch S, Kumar N, Sitruk-Ware R, Nieschlag E (May 2017). "Impact of various progestins with ... Poulin R, Baker D, Poirier D, Labrie F (1991). "Multiple actions of synthetic 'progestins' on the growth of ZR-75-1 human ... It is described as the most potent progestin of the 17α-hydroxyprogesterone group, being about 1,200-fold more potent than ...
Progestins in general largely have the same progestogenic effects however, and in theory, any progestin could be used in ... Progestins are usually taken orally. In contrast to progesterone, most progestins have high oral bioavailability, and can ... There are dozens of clinically used progestins. Certain progestins, namely cyproterone acetate and medroxyprogesterone acetate ... Some progestins, such as medroxyprogesterone acetate and hydroxyprogesterone caproate, are or can be used by intramuscular or ...
Satoskar RS, Bhandarkar SD, Rege NN (1973). "Gonadotropins, Estrogens, and Progestins". Pharmacology and Pharmacotherapeutics. ...
It is sometimes referred to as a "first-generation" progestin. Along with desogestrel, it is one of the only progestins that is ... Norethisterone (NET) is the parent compound of a large group of progestins that includes most of the progestins known as the 19 ... Norethisterone is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological ... Zitzmann M, Rohayem J, Raidt J, Kliesch S, Kumar N, Sitruk-Ware R, Nieschlag E (May 2017). "Impact of various progestins with ...
Pasqualini JR, Paris J, Sitruk-Ware R, Chetrite G, Botella J (April 1998). "Progestins and breast cancer". The Journal of ... Medroxyprogesterone caproate (MPC) is a progestin and a progestogen ester which was synthesized in 1958 but was never marketed ... Pasqualini JR, Ebert C (June 1999). "Biological effects of progestins in breast cancer". Gynecological Endocrinology. 13 (Suppl ... a new class of potent progestins". Journal of the American Chemical Society. 80 (11): 2904-2905. doi:10.1021/ja01544a079. ISSN ...
Certain progestins have been found to stimulate the proliferation of MCF-7 breast cancer cells in vitro, an action that is ... NOMAC is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological target ... It is unclear if these findings may explain the different risks of breast cancer observed with progesterone and progestins in ... Croxatto HB (2000). "Progestin implants". Steroids. 65 (10-11): 681-685. doi:10.1016/S0039-128X(00)00124-0. PMID 11108876. ...
... , also known as 19-norpregn-4-ene-3,20-dione, is a steroidal progestin and close analogue of the sex hormone ... 19-Norprogesterone is the parent compound of a group of medically used progestins, which includes the following: 17α-Hydroxy-19 ... Sitruk-Ware R (April 2004). "Pharmacological profile of progestins". Maturitas. 47 (4): 277-283. doi:10.1016/j.maturitas. ... and is the parent compound of a large group of AAS and progestins that includes norethisterone. 17α-Methylprogesterone ...
... is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the ... Etynodiol diacetate, or ethynodiol diacetate, sold under the brand names Demulen and Femulen among others, is a progestin ... In addition to its progestogenic activity, etynodiol diacetate has weak androgenic activity, and, unlike most progestins but ... Stanczyk FZ (September 2002). "Pharmacokinetics and potency of progestins used for hormone replacement therapy and ...
... is a progestin which is used in birth control pills sold under the brand name Ovral in combination with the estrogen ... Norgestrel is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological ... Norgestrel is sometimes referred to as a "second-generation" progestin. It is marketed widely throughout the world. Norgestrel ... Endrikat J, Gerlinger C, Richard S, Rosenbaum P, Düsterberg B (December 2011). "Ovulation inhibition doses of progestins: a ...
Henzl MR, Edwards JA (10 November 1999). "Pharmacology of Progestins: 17α-Hydroxyprogesterone Derivatives and Progestins of the ... Dydrogesterone is a progestin which was first synthesized by Duphar in the 1950s and was first introduced to the market in 1961 ... Dydrogesterone is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological ... Oral administration of progestins dydrogesterone at least similar live birth rate than vaginal progesterone capsules when used ...
Progestins in birth control pills are sometimes grouped by generation. While the 19-nortestosterone progestins are consistently ... Henzl MR, Edwards JA (10 November 1999). "Pharmacology of Progestins: 17α-Hydroxyprogesterone Derivatives and Progestins of the ... MGA is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological target of ... MGA was first studied in the treatment of breast cancer in 1967, and was one of the first progestins to be evaluated for the ...
Edgren RA, Stanczyk FZ (December 1999). "Nomenclature of the gonane progestins". Contraception. 60 (6): 313. doi:10.1016/S0010- ...
Progestins, and Their Antagonists. pp. 115-160. doi:10.1007/978-1-4612-4096-9_5. ISBN 978-1-4612-8650-9. Onapristone, p. 134, ...
The Population Council also plans to test vaginal rings with two other progestins, ST-1435 and levonorgestrel acetate, alone ... Levonorgestrel acetate (LNG-A), or levonorgestrel 17β-acetate, also known as 3-ketonorgestimate, is a progestin which was never ... "Classification and pharmacology of progestins". Maturitas. 61 (1-2): 171-80. doi:10.1016/j.maturitas.2008.11.013. PMID 19434889 ...
Sobel NB (June 1994). "Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, ... Desogestrel is a progestin medication which is used in birth control pills for women. It is also used in the treatment of ... Desogestrel is a progestin, or a synthetic progestogen, and hence is an agonist of the progesterone receptor, the biological ... Along with norethisterone, it is one of the only progestins that is widely available as a progestogen-only "mini pill" for ...
... (or progestin-only contraception) relies on progestogens alone to achieve contraception. It is ... "Role of progestins in contraception". Acta Obstet Gynecol Scand. 84 (3): 207-16. doi:10.1111/j.0001-6349.2005.00759.x. PMID ...
... so orally active progestins were tried beginning with ethisterone, followed by other progestins as they became available: ... Genital ambiguity due to progestin exposure in pregnancy is thus mostly a topic of historical concern. The first drugs reported ... Loose, Davis S.; Stancel, George M. (2006). "Estrogens and Progestins". In Brunton, Laurence L.; Lazo, John S.; Parker, Keith L ... Wilkins L (March 5, 1960). "Masculinization of female fetus due to use of orally given progestins". JAMA. 172 (10): 1028-32. ...
Classifications for progestin-only contraceptives (POCs) include those for progestin-only implants, depot medroxyprogesterone ... Classifications for progestin-only contraceptives, including implants, depot medroxyprogesterone acetate, and progestin-only ... Categories for Classifying Progestin-Only Contraceptives. 1 = A condition for which there is no restriction for the use of the ... Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes ...
Progestins. Class Summary. When administered orally in the recommended doses to women adequately exposed to exogenous or ...
Progestins have been used for contraception for more than 30 years. The main goal was to develop a contraceptive method devoid ... Role of progestins in contraception Acta Obstet Gynecol Scand. 2005 Mar;84(3):207-16. doi: 10.1111/j.0001-6349.2005.00759.x. ... Progestins have been used for contraception for more than 30 years. The main goal was to develop a contraceptive method devoid ... Progestin-only contraceptives may be preferable in some situations, which have absolute or relative contraindications to ...
Estrogen and Progestin (Oral Contraceptives): learn about side effects, dosage, special precautions, and more on MedlinePlus ... Estrogen and progestin are two female sex hormones. Combinations of estrogen and progestin work by preventing ovulation (the ... Estrogen and Progestin (Oral Contraceptives). pronounced as (ess troe jen) (proe jes tin) ... Many 28-tablet packets have certain color tablets that contain different amounts of estrogen and progestin, but also may have ...
Synthetic steroid hormones with progesterone-like properties are called progestin. Progestin is available as capsules, in ... Progestins are not suitable for people with a history of the following conditions, unless they are using it to treat the ... A combined estrogen and progestin hormone therapy (HT) can prevent this. However, HT can have adverse effects, and it increases ... Progestin is an artificial form of progesterone that is used for medical purposes. ...
Progestins, used in contraceptives and hormone replacement therapy, have been linked to breast cancer. These authors provide a ... They show in a mouse model that synthetic progestins can promote mammary tumour formation by inducing RANKL (receptor activator ... These data show that the RANKL/RANK system controls the incidence and onset of progestin-driven breast cancer. ... show in a mouse model that synthetic progestins can promote mammary tumour formation by inducing the osteoclast differentiation ...
Progestin-Only (drospirenone) Oral Contraceptives: learn about side effects, dosage, special precautions, and more on ... Progestin-only (drospirenone) oral contraceptives are used to prevent pregnancy. Progestin is a female hormone. It works by ... If you want to become pregnant, stop taking progestin-only (drospirenone) contraceptive. Progestin-only contraceptives should ... Progestin-only oral contraceptives are a very effective method of birth control, but they do not prevent the spread of of human ...
A paper with information for the patient will be given to you with your filled prescription, and will provide many details concerning the use of oral contraceptives. Read this paper carefully and ask your health care professional if you need additional information or explanation.. Take this medicine with food to help prevent nausea that might occur during the first few weeks. Nausea usually disappears with continued use or if the medicine is taken at bedtime.. When you begin to use oral contraceptives, your body will require at least 7 days to adjust before a pregnancy will be prevented. You will need to use an additional birth control method for at least 7 days. Some doctors recommend using an additional method of birth control for the first cycle (or 3 weeks) to ensure full protection. Follow the advice of your doctor or other health care professional.. Try to take the doses no more than 24 hours apart to reduce the possibility of side effects and to prevent pregnancy. Since one of the most ...
When progestin therapy doesnt work - an explanation of some of the causes of failure of promotion of estrus and other problems ... For progestins to induce estrus, there must be a degree of cyclicity; *progestin therapy may be beneficial in assisting in ... If it occurs as a result of artificially elevated progestin levels (following progestin treatment) and an undetected uterine ... 2: Squires EL, Stevens WB, McGlothlin DE, Pickett BW. (1979) Effect of oral progestin on the estrous cycle and fertility of ...
Oral progestin can be a reasonable treatment option for many patients with stage 1A endometrial cancer. ... Progestin Tx Reasonably Effective for Early Endometrial Cancer Oral progestin can be a reasonable treatment option for many ... "Progestin treatment appears to be reasonably effective for patients with stage IA, grade 2 to 3 differentiation without ... HealthDay News) - Conservative management with oral progestin can be a reasonable treatment option for many patients with stage ...
Discrepancies from in vitro and in vivo data prompted me to analyze the role of the class II progestin and adipoQ (Paqr) ... P4 amplification of the surge and rapid signaling in the AVPV may occur through its non-classical progestin receptors. Previous ... Discrepancies from in vitro and in vivo data prompted me to analyze the role of the class II progestin and adipoQ (Paqr) ... P4 amplification of the surge and rapid signaling in the AVPV may occur through its non-classical progestin receptors. Previous ...
We have known for many years now that synthetic progestins increase risk for breast cancer. As a research scientist who had ... No question, synthetic progestins were bad for the breasts and should not be used, especially by women who want to reap the ... Synthetic Progestins Raise Breast Cancer Risk. Fast forward about 20 years to present; several more recent meta-analyses of the ... Virtually all forms, of which there are many, of synthetic progestins increased risk to about the same extent. Smaller studies ...
The distribution of progestin receptor mRNA in rat brainstem. Brain Res Gene Expr Patterns. 2002 Oct; 1(3-4):151-7. ...
synthetic progestins and reported the outcomes of interest. Study selection and data extraction were performed by two ... Progesterone was associated with lower breast cancer risk compared to synthetic progestins when each is given in combination ... Limited data suggest differences between progesterone and progestins on cardiovascular risk factors, including cholesterol and ... containing estrogen and a synthetic progestin is associated with an increased risk of breast cancer. It is unclear if ...
Development of estradiol-induced progestin receptor immunoreactivity in the hypothalamus of female guinea pigs. J Neurobiol. ... Development of estradiol-induced progestin receptor immunoreactivity in the hypothalamus of female guinea pigs. ... Development of estradiol-induced progestin receptor immunoreactivity in the hypothalamus of female guinea pigs. ...
Post Tagged with: "progestins" Why are menopausal women still getting a form of HRT thats clearly linked to cancer? There is ...
Progesterone isnt the same as progestins, powerful synthetic hormones that work LIKE progesterone, but dont even come close ... the most commonly prescribed progestin in the U.S..[2. Regidor P-A. Progesterone in Peri- and Postmenopause: A Review. ...
Progestins. Class Summary. Progestins stop endometrial cell proliferation, allowing organized sloughing of cells after ... The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1996 Feb 7. 275(5):370-5. [QxMD MEDLINE Link]. ... Hormone therapy, consisting of an estrogen and a progestin, is needed for women in whom estrogen deficiency remains because ... For primary amenorrhea, hormone therapy, consisting of an estrogen and a progestin, is recommended for women with estrogen ...
Estrogens/Progestins. Class Summary. Estrogen derivatives are approved for the prevention of osteoporosis and relief of ... Estrogens/Progestins-HRT. Class Summary. The combination of conjugated estrogens and medroxyprogesterone reduces bone ... Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Womens Health ...
Progesterone and progestins are discussed as if they are one in the same. But, they are not. They are two very different ... The reason progestins have many side effects is that many women are unable to fully metabolize progestins, and its the ... In addition, progestins can cause acne, nausea, sleep disorders, and hair loss. Progestins block the beneficial effects of ... What Are the Differences Between Progesterone and Progestins?. Both progesterone and progestins will protect against ...
... include the treatment of dysfunctional uterine bleeding, dys-menorrhea, ... Modern Pharmacology with Clinical Applications: Estrogens, Progestins, and Specific Estrogen Receptor Modulators (SERMs) ... Home , , Modern Pharmacology with Clinical Applications , Other clinical uses of estrogens and progestins ... Progestins may be teratogenic during the first trimester of pregnancy. Therefore, if pregnancy is sus-pected, oral ...
TopRx is a nationally recognized pharmacy supplies distributor committed to serving independent pharmacies and other healthcare facilities through outstanding customer service. Order today!
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content ...
The minipill only contains one hormone -- a progestin. How does it work? The hormone in the minipill acts similarly to the ... The minipill, or progestin-only pill (POP), is a method of birth control that contains only one hormone, a progestin. There ... The minipill is different from the combined oral contraceptive (COC or the pill), which contains progestin and estrogen ...
The use of the Mirena, Skyla, Liletta, and Kyleena hormonal IUD supplies synthetic progestins in the gonadal area which are ... If you are wondering whether getting a hormonal IUD inserted or starting progestin-only birth control might have a detrimental ... Its essential for those with acne prone skin to stay away from progestin-only contraceptives. These include the levonorgestrel ... unlikely that you might immediately experience hormonal cystic acne upon insertion of a levonorgestrel IUD or other progestin- ...
Dive into the research topics of Estrogens, progestins, menopause and neurodegeneration: Basic and clinical studies. Together ...
Some release small amounts of the hormone progestin while others are hormone-free. Progestin-only IUDs are available under the ... While progestin-only pills must be taken at exactly the same time every day to prevent pregnancy, theres a little bit more ... A progestin-only method of contraception like the minipill is worth thinking about if you want to avoid the risks of ... If youre looking for a progestin-only birth control option, the minipill isnt your only choice. If taking a pill every day ...
  • Limited data suggest differences between progesterone and progestins on cardiovascular risk factors, including cholesterol and glucose metabolism. (biomedcentral.com)
  • Is There a Difference Between Progesterone and Progestins? (jackomd180.com)
  • Many physicians do not realize that there is a difference between progesterone and progestins so it should not be surprising that many women do not that there is a difference either. (jackomd180.com)
  • And, this is what we see with progesterone and progestins. (jackomd180.com)
  • What Are the Differences Between Progesterone and Progestins? (jackomd180.com)
  • Both progesterone and progestins will protect against endometrial cancer and that's where the similarities stop. (jackomd180.com)
  • My best guess is they think they are progesterone and progestins are one in the same. (jackomd180.com)
  • Unfortunately, the difference between progesterone and progestins can be difficult for even doctors to keep straight. (drmariza.com)
  • One type of progestin, namely depot medroxyprogesterone acetate, can stimulate the appetite control center in the hypothalamus, causing an increase in appetite and body weight. (pkr.ac.id)
  • Estrogen and progestin are two female sex hormones. (medlineplus.gov)
  • Synthetic steroid hormones with progesterone-like properties are called progestin. (medicalnewstoday.com)
  • Progesterone isn't the same as progestins, powerful synthetic hormones that work LIKE progesterone, but don't even come close to replacing the progesterone your body needs. (hormonepharmacist.com)
  • While many types of birth control contain a combination of the hormones estrogen and progestin, what's called the minipill is progestin-only. (ro.co)
  • Now, think of the artificial hormones (prescription Progestins) and the side effects that they will have. (restlesslegsyndromecure.com)
  • There are two types: the copper IUD, which does not contain hormones, and the levonorgestrel (hormonal) IUD, which contains a progestin hormone. (healthychildren.org)
  • Progestin-only oral contraceptives Oral contraceptives (OCs) are steroid hormones that inhibit the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus, thus inhibiting the release of the pituitary hormones that. (msdmanuals.com)
  • Estrogens and progestins are hormones that produce myriad physiological actions. (mhmedical.com)
  • Hormonal medications are often made up of the synthetic (man-made) female hormones: estrogen and progestin. (youngwomenshealth.org)
  • In particular, synthetic progesterone derivatives (progestins) such as medroxyprogesterone acetate (MPA), used in millions of women for hormone replacement therapy and contraceptives, markedly increase the risk of developing breast cancer. (nature.com)
  • And if you were taking a progestogen to help balance the estrogen and protect against its proliferative effects, use bioidentical progesterone, not a synthetic progestin like medroxyprogesterone acetate (Provera) or other synthetic "fake" progesterone. (zrtlab.com)
  • Synthetic progestins may be structurally related to progesterone (e.g., medroxyprogesterone acetate (MPA), dydrogesterone) or to testosterone (e.g., levonorgestrel, drospirenone) with differing potency and pharmacokinetics. (biomedcentral.com)
  • In a survey of 100 thousand French menopausal women, the women who took Progesterone had lower breast cancer rates than women who took medroxyprogesterone, the most commonly prescribed progestin in the U.S..[2. (hormonepharmacist.com)
  • Click here to see molecular structure of estradiol (estrogen), progesterone, testosterone, and medroxyprogesterone acetate (a progestin). (jackomd180.com)
  • Progestin is also the active ingredient in the long-acting injected contraceptive Depo Provera (medroxyprogesterone) and the intrauterine device (IUD) Mirena. (healthywomen.org)
  • Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. (nature.com)
  • These results led to widescale panic among postmenopausal women using conventional estrogen and progestogen (both synthetic progestins and natural progesterone) therapies and a precipitous drop in prescriptions for these forms of HRT [1] . (zrtlab.com)
  • We searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Scopus through 17 May 2016 for studies that enrolled postmenopausal women using progesterone vs. synthetic progestins and reported the outcomes of interest. (biomedcentral.com)
  • Administration of estrogen alone or estrogen-progestin combinations multiplies by 1.2 to 1.8 the relative risk of breast cancer in postmenopausal women. (brainkart.com)
  • 40 years) with endometrioid adenocarcinoma of the uterus who were treated conservatively with oral progestin. (empr.com)
  • MHT regimens typically include estrogen and, for women with an intact uterus, a progestin to protect the endometrium from hyperplasia caused by unopposed estrogen. (biomedcentral.com)
  • The use of estrogen therapy without progesterone (progestin), is associated with an increase in the risk of uterine cancer (endometrial cancer , cancer of the lining of the uterus). (medicinenet.com)
  • Because ET alone can cause uterine cancer (endometrial cancer) (see below), a progestin is administered together with estrogen in women who have a uterus (those who have not undergone a hysterectomy ) to eliminate the increased risk. (medicinenet.com)
  • Thus, the term estrogen/progestin therapy , or EPT, refers to a combination of estrogen and progestin therapy, as is given to a woman who still has a uterus. (medicinenet.com)
  • The term hormone therapy (HT) is a more general term that is used to refer to either administration of estrogen alone (women who have had a hysterectomy), or combined estrogen/progestin therapy (women with a uterus). (medicinenet.com)
  • Thus, the ability of progestins to protect the endometrium from cancer risk is not ob-served in breast tissue. (brainkart.com)
  • Other clinical uses of estrogens and progestins include the treatment of dysfunctional uterine bleeding, dys-menorrhea, endometriosis, and rarely, metastatic pros-tate cancer. (brainkart.com)
  • The combined contraceptives with estrogens and progestins were significantly linked to treatment interruption, with a relative risk of 1,99 (p = 0,005). (bvsalud.org)
  • Progestins are synthetic versions of progesterone found in contraceptives. (drmariza.com)
  • Effective synthetic versions of progesterone, called progestins, have been around since the 1950s. (healthywomen.org)
  • P 4 amplification of the surge and rapid signaling in the AVPV may occur through its non-classical progestin receptors. (umass.edu)
  • Discrepancies from in vitro and in vivo data prompted me to analyze the role of the class II progestin and adipoQ (Paqr) receptors in Jak/Stat signaling. (umass.edu)
  • In lower vertebrates, steroid-induced oocyte maturation is considered to involve membrane-bound progestin receptors. (biomedcentral.com)
  • Two totally distinct classes of putative membrane-bound progestin receptors have been reported in vertebrates. (biomedcentral.com)
  • The recent cloning and sequencing of a gene coding for a membranous progesterone receptor [ 5 ] in African clawed frog ( Xenopus laevis ) brought evidence for the existence of both intracellular and membrane progestin receptors [ 6 ]. (biomedcentral.com)
  • Mifepristone (RU486), a clinical abortion agent and potential endocrine disruptor, binds to progestin and glucocorticoid receptors and has multiple functional importance in reproductive physiology. (nih.gov)
  • Various contraceptive progestin injections are available worldwide. (msdmanuals.com)
  • Maternal use of androgens or high doses of certain weakly androgenic synthetic progestogens (progestins) structurally related to testosterone can masculinize (virilize) the external genitalia of a female fetus during susceptible times in pregnancy. (wikipedia.org)
  • Genital ambiguity due to progestin exposure in pregnancy is thus mostly a topic of historical concern. (wikipedia.org)
  • Progestin-only (drospirenone) oral contraceptives are used to prevent pregnancy. (medlineplus.gov)
  • Unfortunately, mares have the ability to develop follicles, and indeed ovulate follicles, in the face of elevated progestin levels - i.e. during diestrus (the time in between "heat") or pregnancy 3 . (equine-reproduction.com)
  • Progestins may be teratogenic during the first trimester of pregnancy. (brainkart.com)
  • While progestin-only pills must be taken at exactly the same time every day to prevent pregnancy, there's a little bit more flexibility when it comes to taking combined oral contraceptives. (ro.co)
  • They are dangerous because, although progestins also affect ovulation and prepare the uterine lining for pregnancy, it is more structurally similar to testosterone than progesterone. (drmariza.com)
  • Norethindrone (a form of progestin ) is a hormone that prevents pregnancy.While the "mini-pill" is more effective than certain other methods of birth control (such as condoms , cervical cap, diaphragm ), it is less effective than combination hormone ( estrogen and progestin ) birth control because it does not consistently prevent ovulation . (webmd.com)
  • 150 mg intramuscularly or 104 mg subcutaneously), and progestin-only pills (POPs)( Box C1 ) ( Table C1 ). (cdc.gov)
  • With typical use, however, about 9 out of 100 people become pregnant in the first year of use with progestin-only pills. (ro.co)
  • And yes, progestins are found in birth control pills. (restlesslegsyndromecure.com)
  • Combination birth control pills (pills that contain both estrogen and progestin) block ovulation and make the body less receptive to a fertilized egg during ovulation. (healthywomen.org)
  • Some birth control pills, called mini-pills, contain only progestin. (healthywomen.org)
  • If you miss periods and can't take either combination or progestin-only birth control pills, or would simply prefer not to take them, you may need an occasional progestin prescription to balance the unopposed estrogen. (healthywomen.org)
  • Use of menopausal hormonal therapy (MHT)-containing estrogen and a synthetic progestin is associated with an increased risk of breast cancer. (biomedcentral.com)
  • Observational studies suggest that in menopausal women, estrogen and progesterone use may be associated with lower breast cancer risk compared to synthetic progestin. (biomedcentral.com)
  • Unresolved issues remain about dose of estrogen and progestin in relation to risk, and about identification of women for whom short-term use to relieve menopausal symptoms may be safe and effective. (elsevierpure.com)
  • Do Not Use Progestins With Natural Progesterone Otherwise Your Restless Leg Syndrome will NOT be Cured. (restlesslegsyndromecure.com)
  • Synthetic Progestins are different from Natural Progesterone in affecting Restless Leg Syndrome patients. (restlesslegsyndromecure.com)
  • Synthetic Progestins such as Megestrol and Provera compete and fit into with the receptor/binding sites normally reserved for Natural Progesterone. (restlesslegsyndromecure.com)
  • These synthetic prescription Progestins will block Natural Progesterone and prevent Restless Leg Syndrome healing. (restlesslegsyndromecure.com)
  • The most common adverse effect of progestin injections is irregular vaginal bleeding. (msdmanuals.com)
  • A thin, flexible plastic implant that contains a progestin hormone called etonogestrel, which prevent the ovary from releasing an egg. (healthychildren.org)
  • Combinations of estrogen and progestin work by preventing ovulation (the release of eggs from the ovaries). (medlineplus.gov)
  • As a result of this endeavor new methods have been developed: oral progestins, implants, injectables, intrauterine hormonal systems, and vaginal rings. (nih.gov)
  • The distribution of progestin receptor mRNA in rat brainstem. (umassmed.edu)
  • The physiologic effects of a particular progestin depend not only on these properties but also on receptor binding. (biomedcentral.com)
  • Development of estradiol-induced progestin receptor immunoreactivity in the hypothalamus of female guinea pigs. (umassmed.edu)
  • In addition, we show that both mPR beta and PGMRC1, two members of distinct membrane-bound progestin receptor classes, exhibit highly similar ovarian expression profiles during the reproductive cycle with maximum levels during vitellogenesis and a down-expression during late vitellogenesis. (biomedcentral.com)
  • Objectives Previously we have shown in endometrial cells that progesterone (P4) and calcitriol (CAL, 1,25(OH) 2 D 3 ) synergistically promote apoptosis and that progestins induce expression of the vitamin D receptor. (usuhs.edu)
  • Progestin-Only Contraception: Injectables and Implants. (pkr.ac.id)
  • In the case of a hormonal imbalance, an artificially produced version, progestin, may help. (medicalnewstoday.com)
  • Maintaining menstrual cycles, a function of progestins, is important during childbearing years because unopposed estrogen without progesterone increases the risk of endometrial cancer. (healthywomen.org)
  • However, when estrogen was combined with a synthetic progestin to prevent uterine cancer, the breast cancer risk increased 1.5 to 2-fold. (zrtlab.com)
  • This is generally more of an issue in mares that are being treated with long-term progestins to suppress estrus 8 (such as for competition enhancement), but can certainly also occur in mares that are being bred that have not had any uterine pathogenic diagnostics performed or have had only a uterine swab culture performed, rather than a culture and cytology . (equine-reproduction.com)
  • The use of the Mirena, Skyla, Liletta, and Kyleena hormonal IUD supplies synthetic progestins in the gonadal area which are going to suppress the body's production of progesterone dramatically. (integrativeaestheticsboston.com)
  • Findings from a systematic review indicate that levonorgestrel IUD may be preferred over oral progestins in the treatment of non-atypical endometrial hyperplasia [Abu Hashim 2016] . (drugs.com)
  • A shot containing a progestin hormone that prevents the ovaries from releasing an egg. (healthychildren.org)
  • Progestins have been used for contraception for more than 30 years. (nih.gov)
  • Progestin-only contraceptives may be preferable in some situations, which have absolute or relative contraindications to estrogen, side-effects to estrogen containing hormonal contraception, lactation, and comfort and feasibility of formulations for long-term use. (nih.gov)
  • At present, emergency contraception is also performed with progestin. (nih.gov)
  • One method of contraception that has high effectiveness is progestin contraception. (pkr.ac.id)
  • The main thing to remember is that progesterone is produced naturally by your body, and progestin is synthetic. (drmariza.com)
  • The 'minipill,' or progestin-only pill (POP), is a method of birth control that contains only one hormone, a progestin. (birthcontrolpharmacies.com)
  • The risk is slightly greater in women taking estrogen-progestin (conjugated equine estrogens plus medroxyproges-terone acetate) compared with women taking estrogen alone (conjugated equine estrogens). (brainkart.com)
  • Evidence is reviewed relating estrogen alone and estrogen plus progestin to increased risk of breast cancer. (elsevierpure.com)
  • If it occurs as a result of artificially elevated progestin levels (following progestin treatment) and an undetected uterine pathogen is present, it may result in the onset of a significant uterine infection 7 . (equine-reproduction.com)
  • Progestin-only (drospirenone) oral contraceptives come as tablets to take by mouth once a day. (medlineplus.gov)
  • Progestin-only (drospirenone) oral contraceptives come in packs of 28 tablets that have 2 different colors. (medlineplus.gov)
  • Your doctor will tell you when you should start taking your progestin-only (drospirenone) oral contraceptive. (medlineplus.gov)
  • tell your doctor and pharmacist if you are allergic to drospirenone, other progestins, or any other medications. (medlineplus.gov)
  • Much of the treatment involves hormone therapy that suppresses the proliferation of endometriosis lesions.Objective To compare discontinuation rates of pharmacological treatment with estrogen - progestins and progestins medications. (bvsalud.org)
  • Progestin-only oral contraceptives are a very effective method of birth control, but they do not prevent the spread of of human immunodeficiency virus (HIV, the virus that causes acquired immunodeficiency syndrome [AIDS]) and other sexually transmitted diseases. (medlineplus.gov)
  • HealthDay News) - Conservative management with oral progestin can be a reasonable treatment option for many patients with stage 1A endometrial cancer , according to research published in the July issue of Obstetrics & Gynecology . (empr.com)
  • Progestin is commonly used for young patients suffering from endometrial hyperplasia or cancer. (arizona.edu)
  • Adding a progestin to estrogen therapy has been shown to reduce the risk of endometrial hyperplasia, which may be a precursor to endometrial cancer . (medicinenet.com)
  • Hormone therapy, consisting of an estrogen and a progestin, is needed for women in whom estrogen deficiency remains because ovarian function cannot be restored. (medscape.com)
  • In the current study we examined the progestin/vitamin D combination in ovarian cells and searched for other progestin-related effects on vitamin D metabolism that may underlie the novel interaction between progestins and vitamin D, including whether progestins inhibit CYP24A1, the enzyme that renders CAL inactive. (usuhs.edu)
  • Conclusions We show for the first time that progestins and vitamin D synergistically reduce cell viability and induce apoptosis in ovarian cells and that progestins PR-dependently inhibit CAL-induced CYP24A1, thus extending CAL activity. (usuhs.edu)
  • The combination of progestins and vitamin D deserves further consideration as a strategy for inhibiting ovarian carcinogenesis. (usuhs.edu)
  • These data show that the RANKL/RANK system controls the incidence and onset of progestin-driven breast cancer. (nature.com)
  • We already knew from earlier studies published several years before WHI that the synthetic progestins were increasing the incidence of breast cancer [3, Chapter 11] . (zrtlab.com)
  • We conducted a systematic review and meta-analysis to synthesize the existing evidence about the effect of progesterone in comparison to synthetic progestins, each in combination with estrogens, on the risk of breast cancer and cardiovascular events. (biomedcentral.com)
  • Further, breast cancer risk may vary between regimens containing different progestins, with some synthetic progestins exhibiting greater risk than others [ 8 ]. (biomedcentral.com)
  • In contrast to progestins, progesterone in combination with estrogen has not been associated with increased breast cancer [ 8 ]. (biomedcentral.com)
  • Progestin and breast cancer : The missing pieces of a puzzle. (weeksmd.com)
  • Progesterone or the synthetic progestin analogue altrenogest (Regumate 1 ) is commonly used in the mare to cause her to enter estrus (come in to "heat") at an appropriate time. (equine-reproduction.com)
  • Data on the adverse effect of combination estrogen plus progestin used for long durations has only become available over the past decade. (elsevierpure.com)
  • For primary amenorrhea, hormone therapy, consisting of an estrogen and a progestin, is recommended for women with estrogen deficiency. (medscape.com)
  • The reason progestins have many side effects is that many women are unable to fully metabolize progestins, and it's the metabolites that cause many of the problems. (jackomd180.com)
  • Virtually all forms, of which there are many, of synthetic progestins increased risk to about the same extent. (zrtlab.com)
  • Even though progestin can cause similar responses in your body, it also carries a higher risk of negative side effects. (drmariza.com)
  • What if I vomit or have diarrhea after taking the progestin only pill? (womenhelp.org)
  • Many 28-tablet packets have certain color tablets that contain different amounts of estrogen and progestin, but also may have other color tablets which contain an inactive ingredient or a folate supplement. (medlineplus.gov)
  • Another possible situation impacting the suitable use of progestins in an attempt to induce estrus is that the uterine immune function is suppressed by the presence of progestins. (equine-reproduction.com)
  • RANK controls the incidence and onset of progestin-driven mammary cancer. (nature.com)
  • This is perfectly normal, and although not seen in all mares, can lead to a failure of timely onset of estrus following progestin therapy. (equine-reproduction.com)

No images available that match "progestins"